Emeritus Professor Frank Gardiner

Emeritus Professor

UQ Centre for Clinical Research

f.gardiner@uq.edu.au

Emeritus Professor Robert Alexander (‘Frank’) Gardiner is a retired academic urologist with an honorary consultant urological appointment at Royal Brisbane & Women’s Hospital and remains based at University of Queensland Centre for Clinical Research for his ongoing research activities. For his international, national and community service activities, research achievements and clinical commitments, he was honoured as a Member, Order of Australia (AM) in 2010, received a Medal & Certificate of Outstanding Service to Fellowship by the Royal Australasian College of Surgeons in 2012 (again in 2022) and, in 2014, was presented with a Royal Brisbane and Women’s Hospital (RBWH) Distinguished Research Award and made a Fellow Urological Society of Australia and New Zealand.

EP Gardiner was the first to demonstrate the lymph drainage of the human prostate using lymphoscintigraphy, developed and published new surgical techniques and undertook the first dendritic cell vaccine studies in prostate cancer in Australia (including one Randomised Controlled Trial) and, in the quest for an early non-invasive diagnostic test for prostate cancer, reported the presence of abnormal prostatic cells in ejaculate of 75% of men with prostate cancer. Since 2000, with colleagues, he initiated 3 unique and actively participated in the genesis and running of 6 completed and published randomised controlled trials (RCTs)in South East Queensland including the only RCTs on which he is the Principal Investigator of cognition and androgen deprivation therapy and, more recently, robotic and open prostatectomy.

His clinical work has almost exclusively been as a consultant urologist at RBWH from 1980 to 2016. During this time, he served as Head of the Urology Unit and Head of the University Department of Surgery. Among other duties, he undertook 7 public clinical sessions per week for the first 19 of these years. He currently is an adjunct professor at Edith Cowan University and previously held adjunct professorial appointments at Griffith University and with Queensland University of Technology.

In addition to roles in formulating prostate cancer guidelines nationally and internationally, EP Gardiner has been an editorial board member of 7 peer-reviewed international journals fulfilling roles as sub-editor and section editor in two and associate editor in another. Between 2005 and 2012, he initiated and instigated Fingertip Urology (FTU) with international colleagues via BJU International (BJUI). FTU was designed to provide props for patient consultations together with Continuing Professional Development (CPD) for Urologists world-wide, being a one-stop shop for up-to-date information for contemporary Urological Practice via the internet. The free primary slides, in particular, consistently received many hits with this initiative firmly establishing the educational credentials of the BJUI journal. Its successor, BJUI Knowledge, is widely accepted as CPD for urologists throughout the world.

EP Gardiner was invited to the closed membership of the Urological Research Society in 1997 and served as its president in 2009. As well as being a member of a WHO-sponsored committee in 2000, he was a Foundation Member of Executive of Academic Surgeons of Asia 2000 and was a Member of the Advisory Board of the Asian Pacific Prostate Society (APPS) from 2011: he convened the APPS’ annual scientific meeting in Australia in 2013.

Among other commitments, EP Gardiner was a member of Board of Councillors, Cancer Council Queensland 2004-2015 and a member, Board of Directors, Cancer Council Australia 2010-14: he is honoured to be Patron of the Redlands Branch of Cancer Council Queensland. He was a member from 2008 and served as chairman, Medical & Scientific Research Committee, Prostate Cancer Foundation Australia in 2013, was chairman, Medical and Scientific Advisory Committee, Cancer Council Queensland 2006-15 and chairman and member of Executive, Viertel Cancer Research Centre 2006-15.

From 2001-2019, EP Gardiner was a member of the Board of Andrology Australia and was an Advisory Board Member of its successor, Healthy Male until the end of 2021. He continues as a reviewer of the Question Bank, Royal Australasian College of Surgeons first part examination in Pathology having re-joined in 2016: previously, he was a member of the Pathology Committee 2001-2012 (chairman for the last 3 years) and, for 2 years, a member of the Urology Examination (first part) Committees of the Royal Australasian College of Surgeons. Currently, he is also a member of the Research Advisory Committee of the Royal Brisbane and Women’s Hospital Research Foundation.

Qualifications

1991 MD (thesis) University of Queensland

1969 MB BS University of Queensland

1981 Fellow, Royal Australasian College of Surgeons

1973 Fellow, Royal College of Surgeons (England)

Most recent appointments and commitments

Convenor, RACS Senior Surgeons’ Section RACS ASM Brisbane 3^rd May 2022
Member, Research Advisory Committee, Royal Brisbane & Women’s Hospital 2019-
Director, Frontier Foundation, Brisbane. Pty, Ltd 2019
Chairman, Human Ethics Committee Aquesta Pathology 2018
Invited Reviewer GSSE Question Bank, Royal Australasian College of Surgeons 2016-
Patron, Redlands Branch of Cancer Council Queensland 2016-
Emeritus Professor, Faculty of Medicine University of Queensland 2017-
Professor of Urology (Personal Chair) University of Queensland 2005-2016
Adjunct Professor, Edith Cowan University, Western Australia 2013-
Consultant Urologist, Royal Brisbane and Women’s Hospital, 1979-2016
Honorary Consultant Urologist, Royal Brisbane & Women’s Hospital 2017-
Fellow Urological Research Society 2005- (Member 1997-2005: President, 2009)
Chairman, Medical & Scientific Research Committee, Prostate Cancer Foundation Australia 2013
Chairman, Medical and Scientific Advisory Committee, Cancer Council Queensland 2006-15
Chairman and member of Executive, Viertel Cancer Research Centre 2006-15: member 2016
Chairman, Queensland Head & Neck Cancer Centre Independent Scientific Advisory Board 2012-2013
Member, Urology Exam (First part) Committee for Royal Australasian College of Surgeons 2012-3
Member, NHMRC Expert Advisory Committee Evaluating the Evidence for Prostate Specific Antigen (PSA) Testing 2012-3
Royal Brisbane & Women’s Hospital Distinguished Research Medal October 2014
Member, Prostate Cancer Foundation of Australia & Cancer Council Australia Prostate Specific Antigen (PSA) Guidelines Committee 2012-5
Member, Lead Advisory Group, Prostate Cancer Survivorship Research Centre, Prostate Cancer Foundation of Australia & Griffith University 2013
Reviewer Australian Medical Handbook – Australian Prescriber
Member, Board of Councillors, Cancer Council Queensland 2004-2015
Member, Board of Directors, Cancer Council Australia 2010-14
Member of Advisory Board of Andrology Australia 2001-2019
Member of Advisory Board Healthy Male 2019-2022
Member, Advisory Board, Asian Pacific Prostate Society 2011-
Member the Executive Committee of the Australian Prostate Cancer Collaboration 2001
Membership of Editorial Boards of international journals
- BJU International (resigned 2016)
- Urologic Oncology: seminars and original investigations
- World Journal of Urology (resigned 2018)
- Korean Journal of Urology (now Investigative & Clinical Urology)
- Prostate International (Associate Editor)
- Urological Research (1985-92)
- Section Editor, Urology, Australian and New Zealand Journal of Surgery (1992-2009)
Advocate Brisbane Convention and Exhibition Centre
Scientific Convenor, Asian Pacific Prostate Society ASM, Melbourne 2013
Consultant, Swinfen Charitable Trust 2009-

Select roles and previous achievements

Principal, Organising Committee for 50^th Reunion of graduation in Medicine at UQ 2019
Member, Organising Committee for 45^th Reunion of graduation in Medicine at UQ 2014
Instigated and appointed editor of a web-based resource through BJU International webpage, FingerTip Urology, designed to provide props for patient consultations together with CPD for Urologists world-wide in addition to being a one-stop shop for up-to-date information for contemporary Urological Practice 2005-2012
Member, Australian Cancer Network Working Party for the development of Clinical Practice 2008-10
Guidelines for the Management of Advanced Prostate Cancer 2008-2010
Member of WHO-sponsored committee, Stockholm 2000
Member, Steering Committee, Australian Genito-urinary Trials Group 2001
Trustee, Paul Bolton Foundation 1999-2004
Sub-editor of Urology Section of Australia New Zealand Journal of Surgery 1992-2009
Member of Queensland State Committee, Royal Australasian College of Surgeons 1998-2003
Member of Ethics Committee, University of Queensland Dental School 1987-2002
Member of Editorial Board, Urological Research Journal 1985-1992
Member, International Board of Maritime Healthcare 2000-2003
Member, Specialist Advisory Committee for Overseas Doctors for Health Insurance Commission 2001-2003
The Australasian member of GU-Global Trials Group 2000-2005
Foundation Member of Executive of Academic Surgeons of Asia 2000
Member of Medical and Scientific Committee, Australian Kidney Foundation 1986-1999
Member, Specialist Advisory Committee, Health Insurance Commission 2001-2005
Member, Research Advisory Committee, Prostate Cancer Foundation of Australia 2007-13
Chairman (2005), NHMRC Clinical Careers Development Awards Committee (member 2003-2006)
Head of Department of Surgery, University of Queensland 1998-2001
Head of Unit, Department of Urology, Royal Brisbane & Women’s Hospital 1996-1999
President, RMO Society Royal Brisbane Hospital 1975
Secretary to Junior Hospital Doctors’ Mess, Kent & Canterbury Hospital, Canterbury, Kent, 1971-2

Awards

2022 RACS Medal & Certificate of Outstanding Service to Fellowship

2010 Member, Order of Australia (AM)

2014 Royal Brisbane and Women’s Hospital Distinguished Research Award

2014 Frank Gardiner Award instituted for highest score in SSE (Urol) of Australian and New Zealand Urology trainees by Board of Urological Society of Australian & New Zealand

2014 Fellow Urological Society of Australia and New Zealand

2012 RACS Medal & Certificate of Outstanding Service to Fellowship

2008-9 Bruce Pearson Fellow, Australasian Urological Foundation

2008 Paul Bolton Fellow, Royal Australasian College of Surgeons

2008 British Association of Urological Surgeons Prize for the best paper at Urological Society of Australia & New Zealand Annual Scientific Meeting

2004-6 Bruce Pearson Fellow, Australasian Urological Foundation

2002 Alban Gee Prize for best scientific poster, Urological Society Australasia Annual Scientific Meeting

1999 William Rudder Travelling Fellow, Queensland Cancer Fund

1995 Alban Gee Prize for best scientific poster, Urological Society Australasia Annual Scientific Meeting

1987 Alban Gee Prize for best scientific poster, Urological Society Australasia Annual Scientific Meeting

1985 Award for best scientific poster, Urological Society Australasia, Annual Scientific Meeting

Research activities

EP Gardiner pioneered urological research in Queensland such that Brisbane is recognised internationally for innovative studies in urology. He was the first to demonstrate the lymph drainage of the human prostate using lymphoscintigraphy, undertook the first dendritic cell vaccine studies in prostate cancer in Australia (including one Randomised Controlled Trial) and has promoted the use of seminal fluid in the very early detection of prostate cancer which led to development of the Progensa™ PCA3 test by Canadian and Dutch colleagues. Since 2000, with colleagues, he initiated 3 unique and actively participated in the genesis and running of 6 completed and published randomised controlled trials (RCTs)I n South- East Queensland including the only RCT of robotic and open prostatectomy on which he is the Principal investigator. Currently, he is working with colleagues at the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland in developing non-invasive tests for prostate and other cancers.

Some recent grants

Movember: A Phase II randomised controlled trial of high dose vitamin D in localised prostate cancer with intermediate risk of progression. Gurney H, Nair-Shalliker V, Smith D, Gebski V, Patel M, Frydenberg M, Gardiner RA, Kimlin M, Fenech M, Gillatt D. $1 040 370: 2016-20

NHMRC: ASTROID: Active Surveillance and other treatment options for prostate cancer. Schofield P, Juraskova I, Frydenberg M, Chambers S, Gordon L, Gardiner RA. $749 704: 2015-2021

Royal Brisbane & Women’s Hospital Foundation. Combined TMPRSS2:ERG PCA3 and SChLAP1 RNA in Urine for selective detection of Aggressive Prostate Cancer. Yaxley J, Koo K, Trau M, Roberts M, Coughlin G, Gianduzzo T, Lavin M, Gardiner R, Mainwaring. $500 000: 2019-24.

NHMRC: Centre for Research Excellence in Prostate Cancer Survivorship. Chambers SK, Newton R, Scuffham P, Baade P, Galvão D, Dunn J, Smith D, Wittert G, Davis I, Gardiner RA (Frank). $$2,498,842. 2016-20.

NHMRC: Improving sexual health in men with prostate cancer: a randomised controlled trial of exercise and psychosocial therapies. Galvao D, Chambers SK, Newton R, Gardiner RA, Cormie P, Spry N, Taafe D, Joseph D, Hamilton. $561 845. 2014-7

Cancer Council Queensland Strategic Research Partnership: A randomised controlled trial of open and robotic prostatectomy: Integrated multidisciplinary studies to guide patient management. Gardiner RA, Chambers SK, Dunglison N, Yaxley J, Occhipinto S, Carter R, Williams S, Lavin MF. $1 490 000: 2008-17

Other publications

Books

1. Gardiner RA. Book: An Insider’s Perspective of Prostate Cancer: Understanding Effects, Management Options and Consequences. Elsevier Academic Press (3 September 2022) ASIN: BOBD7T3XX2. Page numbers source ISBN: 0443187096.

2. Gardiner RA (1990). Thesis: Experimental development of a reliable technique for replacing damaged segments of upper ureters using autologous urinary tract. Awarded MD by University of Queensland, 14/12/1990.

Journal articles

1. Robinson H, Roberts MJ, Gardiner RA, Hill MM. Extracellular vesicles for precision medicine in prostate cancer – Is it ready for clinical translation? Seminars in Cancer Biology. 2023 Feb; 89:18-29. doi: 10.1016/j.semcancer.2023.01.003 https://espace.library.uq.edu.au/view/UQ:e787db5

2. Yaxley WJ, Mackean J, Desai DJ, Tsang G, Dixon J, Samaratunga H, Delahunt B, Egevad L, Gardiner RA, Yaxley JW. Oncological and urinary outcomes following low‐dose‐rate brachytherapy with a median follow‐up of 11.8 years. BJU Int. 2022 Nov;130 Suppl 3(Suppl 3):40-45. doi: 10.1111/bju.15845 https://espace.library.uq.edu.au/view/UQ:48869f2

3. Schofield P, Gough K, Hyatt A, White A, Frydenberg M, Chambers S, Gordon LG, Gardiner R, Murphy DG, Cavedon L, Richards N, Murphy B, Quinn S, Juraskova I. Correction to: Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partners. Trials. 2021 Jan 27;22(1):97. doi: 10.1186/s13063-021-05070-6.

4. Gardiner RA (2002). Updates in Medicine: Urology. Invited manuscript. Med J Aust 2002; 176 (1): || doi: 10.5694/j.1326-5377.2002.tb04275.x https://www.mja.com.au/journal/2002/176/1/urology

5. GalvãoDA, NewtonRU, ChambersSK, SpryN, Joseph D, GardinerRA, FairmanCM, TaaffeDR. Psychological Distress in Men with Prostate Cancer Undertaking Androgen Deprivation Therapy: Modifying Effects of Exercise from a Year-long Randomised Controlled Trial. Prostate Cancer and Prostatic Diseases. 2021 Sep;24(3):758-766. doi: 10.1038/s41391-021-00327-2. Epub 2021 Feb 8

6. Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer. Roberts MJ, Morton A, Donato P, Kyle S, Pattison DA, Thomas P, Coughlin G, Esler R, Dunglison N, Gardiner RA, Doi SA, Emmett L, Yaxley J. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):655-656 doi: 10.1007/s00259-020-04983-9

Publications

Book Chapters (8)

Journal Articles (206)

Conference Papers (63)

Preprints (2)

Book Chapters

Gardiner, R. A., Chambers, S. K., Williams, S. G., Yaxley, J., Samaratunga, H. and Frydenberg, M. (2014). Prostate cancer part one: detection. Endotext. (pp. ---) Massachusetts, United States of America: MDTEXT.COM.

Roberts, Matthew J., Schirra, Horst, Lavin, Martin F. and Gardiner, Robert A. (2014). NMR-based metabolomics: global analysis of metabolites to address problems in prostate cancer. Cervical, Breast and Prostate Cancer. (pp. 1-43) edited by iConcept Press. Tokwawan, Kowloon, Hong Kong: iConcept Press.

Burger, M. J., Steginga, S. K., Williams, S. G. and Gardiner, R. A. (2006). Prostate cancer. Endotext.com Your Endocrine Source. (pp. 1-118) edited by R. McLachlan. U.S.A.: MDTEXT.COM,INC.

Gardiner, R. (2006). Genitourinary tract. Textbook of Surgery. (pp. 513-527) edited by J. J. Tjandra, G.J.A. Clunie, A.H. Kaye and J.A. Smith. Australia: Blackwell Publishing.

Gardiner, R. A., Burger, M. J., Steginga, S., Schmidt, C., Nicol, D. L., Walsh, T., Lavin, M. F. and Clements, J.A. (2004). Integrating molecular, proteomic and vaccine development, quality of life and psychometric evaluations in a comprehensive research program. Prostate Cancer. (pp. 189-216) edited by J. N. Lucas. U.S.A.: Nova Science.

Gardiner, R. A. (2003). The University Department of Surgery at Royal Brisbane Hospital. History of the Division of Surgery Royal Brisbane Hospital. (pp. 107-126) edited by S. Siu. Herston, Qld.: Division of Surgery, Royal Brisbane Hospital.

Stening, S. and Gardiner, R. A. (2003). Urology. History of the Division of Surgery Royal Brisbane Hospital. (pp. 245-254) edited by S. Siu. Brisbane: Division of Surgery, Royal Brisbane Hospital.

Gardiner, R. A., Burger, M., Clements, J.A. and Lavin, M. F. (2003). Realizing the potential of ejaculate/seminal fluid in detecting and predicting natural history. Prostate Cancer Methods & Protocols. (pp. 199-217) edited by P. J. Russell, P. Jackson and E. A. Kingsley. Totowa, New Jersey: Humana Press.

Journal Articles

Schofield, Penelope, Hyatt, Amelia, White, Alan, White, Fiona, Frydenberg, Mark, Chambers, Suzanne, Gardiner, Robert, Murphy, Declan G., Cavedon, Lawrence, Millar, Jeremy, Richards, Natalie, Murphy, Barbara and Juraskova, Ilona (2024). Co-designing an online treatment decision aid for men with low-risk prostate cancer: navigate. BJUI Compass, 5 (1), 121-141. doi: 10.1002/bco2.279

Robinson, Harley, Roberts, Matthew J., Gardiner, Robert A. and Hill, Michelle M. (2023). Extracellular vesicles for precision medicine in prostate cancer: is it ready for clinical translation?. Seminars in Cancer Biology, 89, 18-29. doi: 10.1016/j.semcancer.2023.01.003

Schofield, Penelope, Gough, Karla, Hyatt, Amelia, White, Alan, Frydenberg, Mark, Chambers, Suzanne, Gordon, Louisa G., Gardiner, Robert, Murphy, Declan G., Cavdon, Lawrence, Richards, Natalie, Murphy, Barbara, Quinn, Stephen and Juraskova, Ilona (2021). Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partners. Trials, 22 (1) 49, 97. doi: 10.1186/s13063-020-04986-9

Zhang, Ying, Kim, Jin-Soo, Wang, Tian-Zhen, Newton, Robert U., Galvão, Daniel A., Gardiner, Robert A., Hill, Michelle M. and Taaffe, Dennis R. (2021). Potential role of exercise induced extracellular vesicles in prostate cancer suppression. Frontiers in Oncology, 11 746040, 746040. doi: 10.3389/fonc.2021.746040

Robinson, Harley, Ruelcke, Jayde E., Lewis, Amanda, Bond, Charles S., Fox, Archa H., Bharti, Vandhana, Wani, Shivangi, Cloonan, Nicole, Lai, Andrew, Margolin, David, Li, Li, Salomon, Carlos, Richards, Renée S., Farrell, Aine, Gardiner, Robert A., Parton, Robert G., Cristino, Alexandre S. and Hill, Michelle M. (2021). Caveolin‐1‐driven membrane remodelling regulates hnRNPK‐mediated exosomal microRNA sorting in cancer. Clinical and Translational Medicine, 11 (4) e381, e381. doi: 10.1002/ctm2.381

Nair-Shalliker, Visalini, Smith, David P., Gebski, Val, Patel, Manish I., Frydenberg, Mark, Yaxley, John W., Gardiner, Robert, Espinoza, David, Kimlin, Michael G., Fenech, Michael, Gillatt, David, Woo, Henry, Armstrong, Bruce K., Rasiah, Krishan, Awad, Nader, Symons, James and Gurney, Howard (2021). High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): Protocol of a phase II randomised controlled trial. BMJ Open, 11 (3) e044055, 1-9. doi: 10.1136/bmjopen-2020-044055

Roberts, Matthew J., Morton, Andrew, Donato, Peter, Kyle, Samuel, Pattison, David A., Thomas, Paul, Coughlin, Geoff, Esler, Rachel, Dunglison, Nigel, Gardiner, Robert A., Doi, Suhail A., Emmett, Louise and Yaxley, John (2021). Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2021), 48, 2, (477-482), 10.1007/s00259-020-04944-2). European Journal of Nuclear Medicine and Molecular Imaging, 48 (2), 655-656. doi: 10.1007/s00259-020-04983-9

Roberts, Matthew J., Morton, Andrew, Donato, Peter, Kyle, Samuel, Pattison, David A., Thomas, Paul, Coughlin, Geoff, Esler, Rachel, Dunglison, Nigel, Gardiner, Robert A., Doi, Suhail A., Emmett, Louise and Yaxley, John (2021). 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48 (2), 477-482. doi: 10.1007/s00259-020-04944-2

Galvão, Daniel A., Newton, Robert U., Chambers, Suzanne K., Spry, Nigel, Joseph, David, Gardiner, Robert A., Fairman, Ciaran M. and Taaffe, Dennis R. (2021). Psychological distress in men with prostate cancer undertaking androgen deprivation therapy: modifying effects of exercise from a year-long randomized controlled trial. Prostate Cancer and Prostatic Diseases, 24 (3), 758-766. doi: 10.1038/s41391-021-00327-2

Nair-Shalliker, Visalini, Bang, Albert, Egger, Sam, Clements, Mark, Gardiner, Robert A., Kricker, Anne, Seibel, Markus J., Chambers, Suzanne K., Kimlin, Michael G., Armstrong, Bruce K. and Smith, David P. (2020). Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer. Scientific Reports, 10 (1) 7736, 1-11. doi: 10.1038/s41598-020-62182-w

Roberts, Matthew J., Macdonald, Alastair, Ranasinghe, Sachinka, Bennett, Harrison, Teloken, Patrick E., Harris, Patrick, Paterson, David, Coughlin, Geoff, Dunglison, Nigel, Esler, Rachel, Gardiner, Robert A., Elliott, Thomas, Gordon, Louisa and Yaxley, John (2020). Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution. Prostate Cancer and Prostatic Diseases, 24 (1), 169-176. doi: 10.1038/s41391-020-0263-x

Roberts, Matthew J., Morton, Andrew, Donato, Peter, Kyle, Samuel, Pattison, David A., Thomas, Paul, Coughlin, Geoff, Esler, Rachel, Dunglison, Nigel, Gardiner, Robert A., Doi, Suhail A., Emmett, Louise and Yaxley, John (2020). 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48 (2), 655-656. doi: 10.1007/s00259-020-04944-2

Newton, Robert U., Galvão, Daniel A., Spry, Nigel, Joseph, David, Chambers, Suzanne K., Gardiner, Robert A., Hayne, Dickon and Taaffe, Dennis R. (2020). Timing of exercise for muscle strength and physical function in men initiating ADT for prostate cancer. Prostate Cancer and Prostatic Diseases, 23 (3), 457-464. doi: 10.1038/s41391-019-0200-z

Donato, Peter, Morton, Andrew, Yaxley, John, Ranasinghe, Sachinka, Teloken, Patrick E., Kyle, Samuel, Coughlin, Geoff, Esler, Rachel, Dunglison, Nigel, Gardiner, Robert A. and Roberts, Matthew J. (2020). 68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?. European Journal of Nuclear Medicine and Molecular Imaging, 47 (8), 1843-1851. doi: 10.1007/s00259-019-04620-0

Occhipinti, Stefano, Zajdlewicz, Leah, Coughlin, Geoffrey D., Yaxley, John W., Dunglison, Nigel, Gardiner, Robert A. and Chambers, Suzanne K. (2019). A prospective study of psychological distress after prostate cancer surgery. Psycho-Oncology, 28 (12) pon.5263, 2389-2395. doi: 10.1002/pon.5263

Yoneyama, Tohru, Tobisawa, Yuki, Kaneko, Tomonori, Kaya, Takatoshi, Hatakeyama, Shingo, Mori, Kazuyuki, Yoneyama, Mihoko Sutoh, Okubo, Teppei, Mitsuzuka, Koji, Duivenvoorden, Wilhelmina, Pinthus, Jehonathan H., Hashimoto, Yasuhiro, Ito, Akihiro, Koie, Takuya, Suda, Yoshihiko, Gardiner, Robert A. and Ohyama, Chikara (2019). Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection. Cancer Science, 110 (8), 2573-2589. doi: 10.1111/cas.14082

Donato, Peter, Morton, Andrew, Yaxley, John, Teloken, Patrick E., Coughlin, Geoff, Esler, Rachel, Dunglison, Nigel, Gardiner, Robert A. and Roberts, Matthew J. (2019). Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospital. World Journal of Urology, 38 (2), 371-379. doi: 10.1007/s00345-019-02774-y

Newton, Robert U., Galvão, Daniel A., Spry, Nigel, Joseph, David, Chambers, Suzanne K., Gardiner, Robert A., Wall, Brad A., Bolam, Kate A. and Taaffe, Dennis R. (2019). Exercise Mode Specificity for Preserving Spine and Hip Bone Mineral Density in Prostate Cancer Patients. Medicine and Science in Sports and Exercise, 51 (4), 607-614. doi: 10.1249/MSS.0000000000001831

Donato, Peter, Roberts, Matthew J., Morton, Andrew, Kyle, Samuel, Coughlin, Geoff, Esler, Rachel, Dunglison, Nigel, Gardiner, Robert A. and Yaxley, John (2019). Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology. European Journal of Nuclear Medicine and Molecular Imaging, 46 (1), 20-30. doi: 10.1007/s00259-018-4160-7

Dadaev, Tokhir, Saunders, Edward J., Newcombe, Paul J., Anokian, Ezequiel, Leongamornlert, Daniel A., Brook, Mark N., Cieza-Borrella, Clara, Mijuskovic, Martina, Wakerell, Sarah, Olama, Ali Amin Al, Schumacher, Fredrick R., Berndt, Sonja I., Benlloch, Sara, Ahmed, Mahbubl, Goh, Chee, Sheng, Xin, Zhang, Zhuo, Muir, Kenneth, Govindasami, Koveela, Lophatananon, Artitaya, Stevens, Victoria L., Gapstur, Susan M., Carter, Brian D., Tangen, Catherine M., Goodman, Phyllis, Thompson, Ian M., Batra, Jyotsna, Chambers, Suzanne, Moya, Leire ... The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium (2018). Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. Nature Communications, 9 (1) 2256. doi: 10.1038/s41467-018-04109-8

Sina, Abu Ali Ibn, Carrascosa, Laura G., Liang, Ziyu, Grewal, Yadveer S., Wardiana, Andri, Shiddiky, Muhammad J. A., Gardiner, Robert A., Samaratunga, Hemamali, Gandhi, Maher K., Scott, Rodney J., Korbie, Darren and Trau, Matt (2018). Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker. Nature Communications, 9 (1) 4915, 4915. doi: 10.1038/s41467-018-07214-w

Matejcic, Marco, Saunders, Edward J., Dadaev, Tokhir, Brook, Mark N., Wang, Kan, Sheng, Xin, Olama, Ali Amin Al, Schumacher, Fredrick R., Ingles, Sue A., Govindasami, Koveela, Benlloch, Sara, Berndt, Sonja I., Albanes, Demetrius, Koutros, Stella, Muir, Kenneth, Stevens, Victoria L., Gapstur, Susan M., Tangen, Catherine M., Batra, Jyotsna, Clements, Judith, Gronberg, Henrik, Pashayan, Nora, Schleutker, Johanna, Wolk, Alicja, West, Catharine, Mucci, Lorelei, Kraft, Peter, Cancel-Tassin, Géraldine, Sorensen, Karina D. ... Gardiner, Robert (2018). Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nature Communications, 9 (1) 4616. doi: 10.1038/s41467-018-06863-1

Koo, Kevin M., Wang, Jing, Richards, Renée S., Farrell, Aine, Yaxley, John W., Samaratunga, Hema, Teloken, Patrick E., Roberts, Matthew J., Coughlin, Geoffrey D., Lavin, Martin F., Mainwaring, Paul N., Wang, Yuling, Gardiner, Robert A. and Trau, Matt (2018). Design and clinical verification of surface-enhanced Raman spectroscopy diagnostic technology for individual cancer risk prediction. ACS Nano, 12 (8), 8362-8371. doi: 10.1021/acsnano.8b03698

Coughlin, Geoffrey D., Yaxley, John W., Chambers, Suzanne K., Occhipinti, Stefano, Samaratunga, Hema, Zajdlewicz, Leah, Teloken, Patrick, Dunglison, Nigel, Williams, Scott, Lavin, Martin F. and Gardiner, Robert A. (2018). Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. The Lancet Oncology, 19 (8), 1051-1060. doi: 10.1016/S1470-2045(18)30357-7

Gordon, Louisa G., Tuffaha, Haitham W., James, Robbie, Keller, Andrew T., Lowe, Anthony, Scuffham, Paul A. and Gardiner, Robert A. (2018). Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis. Urologic Oncology, 36 (3) ARTN 91.e7, e7-e15. doi: 10.1016/j.urolonc.2017.10.024

Taaffe, Dennis R., Galvão, Daniel A., Spry, Nigel, Joseph, David, Chambers, Suzanne K., Gardiner, Robert A., Hayne, Dickon, Cormie, Prue, Shum, David H.K. and Newton, Robert U. (2018). Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition. BJU International, 123 (2), 261-269. doi: 10.1111/bju.14505

Kim, Choung-Soo, Lee, Ji Youl, Chung, Byung Ha, Kim, Wun-Jae, Fai, Ng Chi, Hakim, Lukman, Umbas, Rainy, Ong, Teng Aik, Lim, Jasmine, Letran, Jason L., Chiong, Edmund, Wu, Tong-lin, Lojanapiwat, Bannakij, Turkeri, Levent, Murphy, Declan G., Gardiner, Robert A., Moretti, Kim, Cooperberg, Matthew, Carroll, Peter, Mun, Seong Ki, Hinotsu, Shiro, Hirao, Yoshihiko, Ozono, Seiichiro, Horie, Shigeo, Onozawa, Mizuki, Kitagawa, Yasuhide, Kitamura, Tadaichi, Namiki, Mikio and Akaza, Hideyuki (2017). Report of the Second Asian Prostate Cancer (A-CaP) study meeting. Prostate International, 5 (3), 95-103. doi: 10.1016/j.prnil.2017.03.006

Zajdlewicz, Leah, Hyde, Melissa K., Lepore, Stephen J., Gardiner, Robert A. and Chambers, Suzanne K. (2017). Health-related quality of life after the diagnosis of locally advanced or advanced prostate cancer a longitudinal study. Cancer Nursing, 40 (5), 412-419. doi: 10.1097/NCC.0000000000000432

Galvao, Daniel A., Newton, Robert U., Girgis, Afaf, Lepore, Stephen J., Stiller, Anna, Mihalopoulos, Cathrine, Gardiner, Robert A., Taaffe, Dennis R., Occhipinti, Stefano and Chambers, Suzanne K. (2017). Randomized controlled trial of a peer led multimodal intervention for men with prostate cancer to increase exercise participation. Psycho-Oncology, 27 (1), 199-207. doi: 10.1002/pon.4495

Frydenberg, Mark and Gardiner, Robert Frank A. (2017). Robotic prostatectomy took off, despite a lack of evidence and risks of inequity. Medical Journal of Australia, 207 (2), 90-90.e1. doi: 10.5694/mja16.01121

Armstrong, Bruce K., Barry, Michael J., Frydenberg, Mark, Gardiner, Robert A., Haines, Ian and Carter, Stacy M. (2017). PSA testing for men at average risk of prostate cancer. Public Health Research and Practice, 27 (3) e2731721, 2121-2121. doi: 10.17061/phrp2731721

Yaxley, John W., Lah, Kevin, Yaxley, Julian P., Gardiner, Robert A., Samaratunga, Hema and MacKean, James (2017). Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years. BJU International, 120 (1), 56-60. doi: 10.1111/bju.13659

Thomas, Audrey A., Pearce, Alison, Sharp, Linda, Gardiner, Robert Alexander, Chambers, Suzanne, Aitken, Joanne, Molcho, Michal and Baade, Peter (2017). Socioeconomic disadvantage but not remoteness affects short-term survival in prostate cancer: a population-based study using competing risks. Asia Pacific Journal of Clinical Oncology, 13 (2), e31-e40. doi: 10.1111/ajco.12570

Mervin, Merehau C., Lowe, Anthony, Gardiner, Robert A., Smith, David P., Aitken, Joanne, Chambers, Suzanne K. and Gordon, Louisa G. (2017). What does it cost Medicare to diagnose and treat men with localized prostate cancer in the first year?. Asia-Pacific Journal of Clinical Oncology, 13 (3), 152-159. doi: 10.1111/ajco.12663

Taaffe, Dennis R., Newton, Robert U., Spry, Nigel, Joseph, David, Chambers, Suzanne K., Gardiner, Robert A., Wall, Brad A., Cormie, Prue, Bolam, Kate A. and Galvao, Daniel A. (2017). Effects of different exercise modalities on fatigue in prostate cancer patients undergoing androgen deprivation therapy: a year-long randomised controlled trial. European Urology, 72 (2), 293-299. doi: 10.1016/j.eururo.2017.02.019

Yaxley, John W., Coughlin, Geoffrey D., Chambers, Suzanne K., Dunglison, Nigel and Gardiner, Robert A. (2017). Assessing robot-assisted laparoscopic prostatectomy - reply. Lancet, 389 (10071), 800-801. doi: 10.1016/S0140-6736(17)30508-1

Roberts, M.J., Richards, R.S., Chow, C.W.K., Buck, M., Yaxley, J., Lavin, M.F., Schirra, H.J. and Gardiner, R.A. (2017). Seminal plasma enables selection and monitoring of active surveillance candidates using nuclear magnetic resonance-based metabolomics: A preliminary investigation. Prostate International, 5 (4), 149-157. doi: 10.1016/j.prnil.2017.03.005

Chambers, Suzanne K., Occhipinti, Stefano, Foley, Elizabeth, Clutton, Samantha, Legg, Melissa, Berry, Martin, Stockler, Martin R., Frydenberg, Mark, Gardiner, Robert A., Lepore, Stephen J., Davis, Ian D. and Smith, David P. (2017). Mindfulness-based cognitive therapy in advanced prostate cancer: a randomized controlled trial. Journal of Clinical Oncology, 35 (3), 291-297. doi: 10.1200/JCO.2016.68.8788

Gardiner, Robert A., Mainwaring, Paul and Lavin, Martin F. (2016). Integrating molecular profiling of liquid biopsy samples with a calculator algorithm to detect high-risk prostate cancer. European Urology, 70 (5), 749-750. doi: 10.1016/j.eururo.2016.05.012

Chambers, Suzanne K., Foley, Elizabeth, Clutton, Samantha, McDowall, Robert, Occhipinti, Stefano, Berry, Martin, Stockler, Martin R., Lepore, Stephen J., Frydenberg, Mark, Gardiner, Robert A., Davis, Ian D. and Smith, David P. (2016). The role of mindfulness in distress and quality of life for men with advanced prostate cancer. Quality of Life Research, 25 (12), 3027-3035. doi: 10.1007/s11136-016-1341-3

Roberts, Matthew J., Hattwell, Jake P. N., Chow, Clement W. K., Lavin, Martin, Pierens, Gregory K., Gardiner, Robert A. and Schirra, Horst Joachim (2016). Tartrate inhibition of prostatic acid phosphatase improves seminal fluid metabolite stability. Metabolomics, 12 (11) 162, 162.1-162.14. doi: 10.1007/s11306-016-1102-x

Hill, Michelle M. and Gardiner, Robert A. (2016). Prospecting for prostate cancer with precision medicine. Translational Cancer Research, 5 (S4), S865-S867. doi: 10.21037/tcr.2016.10.18

Gianduzzo, Troy R. J., Gardiner, Robert A., Rashid, Prem, Young, Rhys, Frydenberg, Mark and Kelly, Sarah (2016). Impact of branding on public awareness of healthcare-related governing bodies: a pilot study of the Urological Society of Australia and New Zealand brand. BJU International, 118 (S3), 23-29. doi: 10.1111/bju.13469

Yaxley, John W., Coughlin, Geoffrey D., Chambers, Suzanne K., Occhipinti, Stefano, Samaratunga, Hema, Zajdlewicz, Leah, Dunglison, Nigel, Carter, Rob, Williams, Scott, Payton, Diane J., Perry-Keene, Joanna, Lavin, Martin F. and Gardiner, Robert A. (2016). Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. The Lancet, 388 (10049), 1057-1066. doi: 10.1016/S0140-6736(16)30592-X

Roberts, Matthew J., Richards, Renee S., Chow, Clement W. K., Doi, Suhail A. R., Schirra, Horst Joachim, Buck, Marion, Samaratunga, Hemamali, Perry-Keene, Joanna, Payton, Diane, Yaxley, John, Lavin, Martin F. and Gardiner, Robert A. (2016). Prostate-based biofluids for the detection of prostate cancer: a comparative study of the diagnostic performance of cell-sourced RNA biomarkers. Prostate International, 4 (3), 97-102. doi: 10.1016/j.prnil.2016.04.002

Galvao, Daniel A., Taaffe, Dennis R., Spry, Nigel, Gardiner, Robert A., Taylor, Renea, Risbridger, Gail P., Frydenberg, Mark, Hill, Michelle, Chambers, Suzanne K., Stricker, Phillip, Shannon, Tom, Hayne, Dickon, Zopf, Eva and Newton, Robert U. (2016). Enhancing active surveillance of prostate cancer: the potential of exercise medicine. Nature Reviews Urology, 13 (5), 258-265. doi: 10.1038/nrurol.2016.46

Hyde, M. K., Newton, R. U., Galvao, D. A., Gardiner, R. A., Occhipinti, S., Lowe, A., Wittert, G. A. and Chambers, S. K. (2016). Men's help-seeking in the first year after diagnosis of localised prostate cancer. European Journal of Cancer Care, 26 (2) e12497, e12497. doi: 10.1111/ecc.12497

Williams, Scott, Yaxley, John W., Coughlin, Geoffrey D. and Gardiner, Robert A. (2016). A randomised control trial of salvage radiotherapy and androgen deprivation therapy following prostatectomy: commentary on five year follow-up findings. Translational Andrology and Urology, 5 (6), 971-973. doi: 10.21037/tau.2016.11.15

Bennett, H.Y., Roberts, M.J., Doi, S.A.R. and Gardiner, R.A. (2015). The global burden of major infectious complications following prostate biopsy. Epidemiology and Infection, 144 (8), 1-8. doi: 10.1017/S0950268815002885

Chambers, Suzanne K., Scuffman, Paul A., Baade, Peter D., Lowe, Anthony P., Dunn, Jeff, Galvão, Daniel A., Gordon, Louisa, Smith, David P., Sandoe, David F., Wootten, Addie C., Spry, Nigel A., Gardiner, Robert A., Davis, Ian D. and Newton, Robert U. (2015). Advancing prostate cancer survivorship research in Australia. Cancer Forum, 39 (3), 204-209.

Gordon, L. G., Walker, S. M., Mervin, M. C., Lowe, A., Smith, D. P., Gardiner, R. A. and Chambers, S. K. (2015). Financial toxicity: a potential side-effect of prostate cancer treatment among Australian men. European Journal of Cancer Care, 26 (1) e12392, 1-10. doi: 10.1111/ecc.12392

Degeling, Chris, Rychetnik, Lucie, Pickles, Kristen, Thomas, Rae, Doust, Jennifer A., Gardiner, Robert A., Glasziou, Paul, Newson, Ainsley J. and Carter, Stacy M. (2015). “What should happen before asymptomatic men decide whether or not to have a PSA test?” A report on three community juries. Medical Journal of Australia, 203 (8), 335.e1-335.e6. doi: 10.5694/mja15.00164

Alexander, Kimberley E., Chambers, Suzanne, Spurdle, Amanda B., Batra, Jyotsna, Lose, Felicity, O'Mara, Tracy A., Gardiner, Robert A., Aitken, Joanne F., Clements, Judith A., Kedda, Mary-Anne and Janda, Monika (2015). Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general population. Quality of Life Research, 24 (9), 2183-2193. doi: 10.1007/s11136-015-0950-6

Ashrafi, Darius, Baade, Peter, Yaxley, John, Roberts, Matthew J., Williams, Scott and Gardiner, Robert A. (2015). Long-term Survival Outcomes for Men Who Provided Ejaculate Specimens for Prostate Cancer Research: Implications for Patient Management. European Urology Focus, 1 (2), 200-206. doi: 10.1016/j.euf.2015.04.002

Chambers, Suzanne K., Occhipinti, Stefano, Schover, Leslie, Nielsen, Lisa, Zadlewicz, Leah, Clutton, Samantha, Halford, Kim, Gardiner, Robert A. and Dunn, Jeff (2015). A randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer and their female partners. Psycho-oncology, 24 (7), 748-756. doi: 10.1002/pon.3726

Ilic, Dragan, Jammal, Walid, Chiarelli, Pauline, Gardiner, Robert A, Hughes, Suzanne, Stefanovic, Dana and Chambers, Suzanne K (2015). Assessing the effectiveness of decision aids for decision making in prostate cancer testing: A systematic review. Psycho-Oncology, 24 (10), 1303-1315. doi: 10.1002/pon.3815

Roberts, Matthew J., Chow, Clement W., Schirra, Horst J., Richards, Renee, Buck, Marion, Selth, Luke A., Doi, Suhail A. R., Samaratunga, Hema, Perry-Keene, Joanna, Payton, Diane, Yaxley, John, Lavin, Martin F. and Gardiner, Robert A. (2015). Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer. Prostate, 75 (5), 539-549. doi: 10.1002/pros.22942

Chambers, Suzanne K., Lowe, Anthony, Hyde, Melissa K., Zajdlewicz, Leah, Gardiner, Robert A., Sandoe, David and Dunn, Jeff (2015). Defining Young in the Context of Prostate Cancer. American Journal of Men's Health, 9 (2), 103-114. doi: 10.1177/1557988314529991

Roberts, Matthew J., Richards, Renee S., Gardiner, Robert A. and Selth, Luke A. (2015). Seminal fluid: A useful source of prostate cancer biomarkers?. Biomarkers in Medicine, 9 (2), 77-80. doi: 10.2217/BMM.14.110

Galvao, Daniel A., Newton, Robert U., Gardiner, Robert A., Girgis, Afaf, Lepore, Stephen J., Stiller, Anna, Mihalopolous, Cathrine, Occhipinti, Stefano and Chambers, Suzanne K. (2015). Compliance to exercise-oncology guidelines in prostate cancer survivors and associations with psychological distress, unmet supportive care needs, and quality of life. Psycho-Oncology, 24 (10), 1241-1249. doi: 10.1002/pon.3882

Gordon, Lachlan A. N., Yaxley, John, Frydenberg, Mark, Williams, Scott G and Gardiner, Robert A. (2015). Changing status of investigations for prostate cancer detection. Cancer Forum, 39 (3), 164-168.

Gardiner, Robert A., Yaxley, John, Pakenham, Kenneth I., Green, Heather, Mactaggart, Peter, Watson, Roger, Swanson, Cheryl and Nicol, David L. (2015). Patients who receive androgen deprivation therapy risk adverse cognitive changes. Journal of Clinical Oncology, 27 (9), 1-2. doi: 10.1200/JCO.2015.63.5698

Dreyton, Ross M., Rehman, Ishtiaq , Clarke, Raymond , Zhao, Zhongming, Pang, Karl , Miah, Saiful , Stoher, Robert , Hartmann, Arndt , Blizard, Sheila, Lavin, Martin, Bryant, Helen E. , Martens-Uznova, Elena S., Jenster, Guido, Hamdy, Freddie C., Gardiner, Robert A. and Catto, James W. F. (2015). Identification and diagnostic performance of a small RNA within the PCA3 and BMCC1 gene locus that potentially targets mRNA. Cancer Epidemiology, Biomarkers and Prevention, 24 (1), 268-275. doi: 10.1158/1055-9965.EPI-14-0377

Thomas, Rae, Glasziou, Paul, Rychetnik, Lucie, Mackenzie, Geraldine, Gardiner, Robert A. and Doust, Jenny (2014). Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening. BMJ Open, 4 (12) e005691, e005691.1-e005691.9. doi: 10.1136/bmjopen-2014-005691

Selth, Luke A., Roberts, Matthew J., Chow, Clement W. K., Marshall, Villis R., Doi, Suhail A. R., Vincent, Andrew D., Butler, Lisa M., Lavin, Martin F., Tilley, Wayne D. and Gardiner, Robert A. (2014). Human seminal fluid as a source of prostate cancer specific microRNA biomarkers. Endocrine - Related Cancer, 21 (4), L17-L21. doi: 10.1530/ERC-14-0234

Roberts, Matthew J., Williamson, Deborah A., Hadway, Paul, Doi, Suhail A. R., Gardiner, Robert A. and Paterson, David L. (2014). Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis. International Journal of Antimicrobial Agents, 43 (4), 301-309. doi: 10.1016/j.ijantimicag.2014.01.008

Moon, Hyeongsun, Hill, Michelle M., Roberts, Matthew J., Gardiner, Robert A. and Brown, Andrew J. (2014). Statins: protectors or pretenders in prostate cancer?. Trends in Endocrinology and Metabolism, 25 (4), 188-196. doi: 10.1016/j.tem.2013.12.007

Cormie, Prue, Chambers, Suzanne K., Newton, Robert U., Gardiner, Robert A., Spry, Nigel, Taaffe, Dennis R., Joseph, David, Hamid, M. Akhlil, Chong, Peter, Hughes, David, Hamilton, Kyra and Galvao, Daniel A. (2014). Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies. Bmc Cancer, 14 (1) 199. doi: 10.1186/1471-2407-14-199

Gardiner, Robert A., Coughlin, Geoffrey D., Yaxley, John W., Dunglison, Nigel T., Occhipinti, Stefano, Younie, Sandra J., Carter, Rob C., Williams, Scott G., Medcraft, Robyn J., Samaratunga, Hema M., Perry-Keene, Joanna L., Payton, Diane J., Lavin, Martin F. and Chambers, Suzanne K. (2014). A progress report on a prospective randomised trial of open and robotic prostatectomy. European Urology, 65 (3), 512-515. doi: 10.1016/j.eururo.2013.10.031

Rychetnik, Lucie, Doust, Jenny, Thomas, Rae, Gardiner, Robert, MacKenzie, Geraldine and Glasziou, Paul (2014). A community jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening - a qualitative analysis. BMJ Open, 4 (4) e004682, e004682. doi: 10.1136/bmjopen-2013-004682

McDowell, M. E., Occhipinti, S., Gardiner, R. A. and Chambers, S. K. (2013). Prevalence and predictors of cancer specific distress in men with a family history of prostate cancer. Psycho-Oncology, 22 (11), 2496-2504. doi: 10.1002/pon.3312

Harris, Janelle L., Richards, Renee S., Chow, Clement W. K., Lee, Soon, Kim, Misook, Buck, Marion, Teng, Linda, Clarke, Raymond, Gardiner, Robert A. and Lavin, Martin F. (2013). BMCC1 Is an AP-2 associated endosomal protein in prostate cancer cells. PloS One, 8 (9) e73880, e73880.1-e73880.15. doi: 10.1371/journal.pone.0073880

Lose, Felicity, Batra, Jyotsna, O'Mara, Tracy, Fahey, Paul, Marquart, Louise, Eeeles, Ros A., Easton, Douglas F., Olama, Ali Amin Al, Kote-Jarai, Zsofia, Guy, Michelle, Muir, Kenneth, Lophatananon, Artitaya, Rahman, Aneela A., Neal, David E., Hamdy, Freddie C., Donovan, Jenny L., Chambers, Suzanne, Gardiner, Robert A., Aitken, Joanne F., Yaxley, John, Alexander, Kimberly, Clements, Judith A., Spurdle, Amanda B., Kedda, Mary-Anne and Australian Prostate Cancer BioResearch (2013). Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. Urologic Oncology: Seminars and Original Investigations, 31 (5), 635-643. doi: 10.1016/j.urolonc.2011.05.011

Baade, Peter D., Youlden, Danny R., Cramb, Susanna M., Dunn, Jeff and Gardiner, Robert A. (2013). Epidemiology of prostate cancer in the Asia-Pacific region. Prostate International, 1 (2), 47-58. doi: 10.12954/PI.12014

Chambers, Suzanne K., Ferguson, Megan, Gardiner, R. A., Aitken, Joanne and Occhipinti, Stefano (2013). Intervening to improve psychological outcomes for men with prostate cancer. Psycho-Oncology, 22 (5), 1025-1034. doi: 10.1002/pon.3095

Roberts, Matthew J., Parambi, Anisha, Barrett, Lucinda, Hadway, Paul, Gardiner, Robert A. (Frank), Hajkowicz, Krispin M. and Yaxley, John (2013). Multifocal abscesses due to multiresistant Escherichia coli after trans rectal ultrasound-guided prostate biopsy. Medical Journal of Australia, 198 (5), 282-284. doi: 10.5694/mja12.11719

Chambers, Suzanne K., Smith, David P., Berry, Martin, Lepore, Stephen J., Foley, Elizabeth, Clutton, Samantha, McDowall, Robert, Occhipinti, Stefano, Frydenberg, Mark and Gardiner, Robert A. (2013). A randomised controlled trial of a mindfulness intervention for men with advanced prostate cancer. BMC Cancer, 13 (1) 89. doi: 10.1186/1471-2407-13-89

Chambers, Suzanne K., Schover, Leslie, Halford, Kim, Ferguson, Megan, Gardiner, R. A., Occhipinti, Stefano and Dunn, Jeff (2013). ProsCan for Couples: a feasibility study for evaluating peer support within a controlled research design. Psycho-Oncology, 22 (2), 475-479. doi: 10.1002/pon.2110

Yaxley, Julian, Yaxley, John, Gardiner, Robert and Yaxley, William (2013). Prostate cancer: active surveillance as a management option. Australian Family Physician, 42 (1), 74-76.

Chambers, Suzanne Kathleen, Hyde, Melissa Karen, Ip, David Fu-Keung, Dunn, Jeffrey Charles and Gardiner, Robert Alexander (2013). Systematic Review of Research into the Psychological Aspects of Prostate Cancer in Asia: What do we Know?. Asian Pacific Journal of Cancer Prevention, 14 (4), 2621-2626. doi: 10.7314/APJCP.2013.14.4.2621

Baade, Peter D., Youlden, Danny R., Gardiner, Robert A., Ferguson, Megan, Aitken, Joanne F., Yaxley, John and Chambers, Suzanne K. (2012). Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia. BJU International, 110 (11b), E712-E719. doi: 10.1111/j.1464-410X.2012.011533.x

Gardiner, Robert ('Frank') A., Yaxley, John and Baade, Peter D. (2012). Integrating disparate snippets of information in an approach to PSA testing in Australia and New Zealand. BJU International, 110 (S4), 35-37. doi: 10.1111/j.1464-410X.2012.11616.x

Newton, Robert U., Taaffe, Dennis R., Spry, Nigel, Cormie, Prue, Chambers, Suzanne K., Gardiner, Robert A., Shum, David H. K., Joseph, David and Galvao, Daniel A. (2012). Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?. Bmc Cancer, 12 (Article number432) 432, 432-1-432-8. doi: 10.1186/1471-2407-12-432

Lose, Felicity, Srinivasan, Srilakshmi, O'Mara, Tracy, Marquart, Louise, Chambers, Suzanne, Gardiner, Robert A., Aitken, Joanne F., Spurdle, Amanda B., Batra, Jyotsna, Clements, Judith A., the Australian Prostate Cancer BioResource and Samaratunga, Hema (2012). Genetic Association of the KLK4 Locus with Risk of Prostate Cancer. PLoS One, 7 (9) e44520, e44520-1-e44520-14. doi: 10.1371/journal.pone.0044520

Gardiner, Robert A., Yaxley, John, Coughlin, Geoff, Dunglison, Nigel, Occhipinti, Stefano, Younie, Sandra, Carter, Rob, Williams, Scott, Medcraft, Robyn J., Bennett, Nigel, Lavin, Martin F. and Chambers, Suzanne Kathleen (2012). A randomised trial of robotic and open prostatectomy in men with localised prostate cancer. BMC Cancer, 12 (1) 189, 189.1-189.6. doi: 10.1186/1471-2407-12-189

Lose, Felicity, Lawrence, Mitchell G., Srinivasan, Srilakshmi, O'Mara, Tracy, Marquart, Louise, Chambers, Suzanne, Gardiner, Robert A., Aitken, Joanne F., Spurdle, Amanda B., Batra, Jyotsna, Clements, Judith A. and Australian Prostate Canc BioResour (2012). The kallikrein 14 gene is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressiveness. Biological Chemistry, 393 (5), 403-412. doi: 10.1515/hsz-2011-0268

Gardiner, R. A. (2012). Prostate cancer incidence in Australia correlates inversely with solar radiation. BJU International, 109 (s3), 71-71. doi: 10.1111/j.1464-410X.2012.11051.x

Baade, Peter D., Gardiner, Robert A., Ferguson, Megan, Youlden, Danny R., Aitken, Joanne F., Yaxley, John and Chambers, Suzanne K. (2012). Factors associated with diagnostic and treatment intervals for prostate cancer in Queensland, Australia: A large cohort study. Cancer Causes and Control, 23 (4), 625-634. doi: 10.1007/s10552-012-9931-z

McDowell, Michelle E., Occhipinti, Stefano, Gardiner, Robert A. and Chambers, Suzanne K. (2012). Patterns of prostate-specific antigen (PSA) testing in Australian men: The influence of family history. BJU International, 109 (s3), 64-70. doi: 10.1111/j.1464-410X.2012.11050.x

Patterson, Imogen Y. L., Robertus, Linda M., Gwynne, Raymond A. and Gardiner, Robert A. (2012). Genitourinary tuberculosis in Australia and New Zealand. BJU International, 109 (s3), 27-30. doi: 10.1111/j.1464-410X.2012.11041.x

Batra, Jyotsna, Lose, Felicity, Chambers, Suzanne, Gardiner, Robert A., Aitken, Joanne, Yaxley, John, Clements, Judith A. and Spurdle, Amanda B. (2011). A replication study examining novel common single nucleotide polymorphisms identified through a prostate cancer genome-wide association study in a Japanese population. American Journal of Epidemiology, 174 (12), 1391-1395. doi: 10.1093/aje/kwr271

Zenzmaier, Christoph, Heitz, Martin, Klocker, Helmut, Buck, Marion, Gardiner, Robert A. and Berger, Peter (2011). Elevated levels of Dickkopf-related protein 3 in seminal plasma of prostate cancer patients. Journal of Translational Medicine, 9 (1) 193, 193.1-193.7. doi: 10.1186/1479-5876-9-193

Batra, Jyotsna, Lose, Felicity, O'Mara, Tracy, Marquart, Louise, Stephens, Carson, Alexander, Kimberly, Srinivasan, Srilakshmi, Eeles, Rosalind A., Easton, Douglas F., Olama, Ali Amin Al, Kote-Jarai, Zsofia, Guy, Michelle, Muir, Kenneth, Lophatananon, Artitaya, Rahman, Aneela A, Neal, David E., Hamdy, Freddie C., Donovan, Jenny L., Chambers, Suzanne, Gardiner, Robert A., Aitken, Joanne, Yaxley, John, Kedda, Mary-Anne, Clements, Judith A. and Spurdle, Amanda B. (2011). Association between prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in australia and a meta-analysis of GWAS data. PLoS One, 6 (11) e26527, e26527-1-e26527-8. doi: 10.1371/journal.pone.0026527

Foley, Charlotte L., Greenwell, Tamsin J. and Gardiner, Robert A. (2011). Urethral diverticula in females. BJU International, 108 (Supp. 2), 20-23. doi: 10.1111/j.1464-410X.2011.10714.x

Chen, Alice C.-H., Waterboer, Tim, Keleher, Annie, Morrison, Beth, Jindal, Shalini, McMillan, Denise, Nicol, David, Gardiner, Robert A., McMillan, Nigel A. J. and Antonsson, Annika (2011). Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients. Pathology and Oncology Research, 17 (3), 613-617. doi: 10.1007/s12253-010-9357-4

Woo, Henry H., Gillman, Michael P., Gardiner, Robert, Marshall, Villis and Lynch, William J. (2011). A practical approach to the management of lower urinary tract symptoms among men. Medical Journal of Australia, 195 (1), 34-39. doi: 10.5694/j.1326-5377.2011.tb03185.x

Chambers, Suzanne K., Newton, Robert U., Girgis, Afaf, Nielsen, Lisa, Lepore, Stephen, Mihalopoulos, Cathrine, Gardiner, R. A., Galvao, Daniel A. and Occhipinti, Stefano (2011). Living with prostate cancer: Randomised controlled trial of a multimodal supportive care intervention for men with prostate cancer. BMC Cancer, 11 (1) 317, 317.1-317.8. doi: 10.1186/1471-2407-11-317

Gardiner, Robert A., Gwynne, Raymond A. and Roberts, Sally A. (2011). Perinephric abscess. BJU International, 107 (Suppl. 3), 20-23. doi: 10.1111/j.1464-410X.2011.10050.x

Baade, Peter D., Youlden, Danny R., Coory, Michael D., Gardiner, Robert A. and Chambers, Suzanne K. (2011). Urban-rural differences in prostate cancer outcomes in Australia: What has changed?. Medical Journal of Australia, 194 (6), 293-296. doi: 10.5694/j.1326-5377.2011.tb02977.x

Roberts, Matthew J., Schirra, Horst J., Lavin, Martin F. and Gardiner, Robert A. (2011). Metabolomics: A novel approach to early and noninvasive prostate cancer detection. Korean Journal of Urology, 52 (2), 79-89. doi: 10.4111/kju.2011.52.2.79

Baade, Peter D., Aitken, Joanne F., Ferguson, Megan, Gardiner, Robert A. and Chambers, Suzanne K. (2010). Diagnostic and treatment pathways for men with prostate cancer in Queensland: Investigating spatial and demographic inequalities. BMC Cancer, 10 (452) 452, 1-8. doi: 10.1186/1471-2407-10-452

Clarke, Raymond A., Schirra, Horst J., Catto, James W., Lavin, Martin F. and Gardiner, Robert A. (2010). Markers for detection of prostate cancer. Cancers, 2 (2), 1125-1154. doi: 10.3390/cancers2021125

Bennett, Nigel C., Gardiner, Robert A., Hooper, John D., Johnson, David W. and Gobe, Glenda C. (2010). Molecular cell biology of androgen receptor signalling. International Journal of Biochemistry and Cell Biology, 42 (6), 813-827. doi: 10.1016/j.biocel.2009.11.013

Smith, David P., Banks, Emily, Clements, Mark S., Gardiner, Robert A. and Armstrong, Bruce K. (2010). Evidence-based uncertainty: Recent trial results on prostate-specific antigen testing and prostate cancer mortality. Medical Journal of Australia, 192 (2), 110-110. doi: 10.5694/j.1326-5377.2010.tb03438.x

Smith, David P., Banks, Emily, Clements, Mark S., Gardiner, Robert A. and Armstrong, Bruce K. (2010). Evidence-based uncertainty: recent trial results on prostate-specific antigen testing and prostate cancer mortality REPLY. Medical Journal of Australia, 192 (2), 110-110.

Lavin, Martin F., Clarke, Raymond and Gardiner, Robert A. (2009). Differential expression of PCA3 and BMCC1 in prostate cancer. The Prostate, 69 (16), 1713-1714. doi: 10.1002/pros.21068

Gardiner, Robert A. (2009). Editorial comment. Journal of Urology, 182 (5), 2121-2121. doi: 10.1016/j.juro.2009.07.151

McDowell, M.E., Occhipinti, S., Gardiner, R.A., Baade, P.D. and Steginga, S.K. (2009). A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer. European Journal of Cancer Care, 18 (6), 545-555. doi: 10.1111/j.1365-2354.2008.01046.x

Eeles, R. A., Kote-Jarai, Z., Al Olama, A. A., Giles, G. G., Guy, M., Severi, G., Muir, K., Hopper, J. L., Henderson, B. E., Haiman, C. A., Schleutker, J., Hamdy, F. C., Neal, D. E., Donovan, J. L., Stanford, J. L., Ostrander, E. A., Ingles, S. A., John, E. M., Thibodeau, S. N., Schaid, D., Park, J. Y., Spurdle, A., Clements, J., Dickinson, J. L., Maier, C., Vogel, W., Dork, T., Rebbeck, T. R., Cooney, K. A. ... Easton, D. F. (2009). Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nature Genetics, 41 (10), 1116-1121. doi: 10.1038/ng.450

Smith, David P., Banks, Emily, Clements, Mark S., Gardiner, Robert A. and Armstrong, Bruce K. (2009). Evidence-based uncertainty: recent trial results on prostate-specific antigen testing and prostate cancer mortality. Medical Journal of Australia, 191 (4), 199-200. doi: 10.5694/j.1326-5377.2009.tb02752.x

Gardiner, Robert A., Sweeney, Christopher and Tilley, Wayne D. (2009). Testosterone therapy in castrate-resistant prostate cancer: a possible new approach. European Urology, 56 (2), 245-246. doi: 10.1016/j.eururo.2009.04.030

Newton, Robert U., Taaffe, Dennis R., Spry, Nigel, Gardiner, Robert A., Levin, Gregory, Wall, Bradley, Joseph, David, Chambers, Suzanne K. and Galvao, Daniel A. (2009). A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer. BMC Cancer, 9 (210) 210, xx-xx. doi: 10.1186/1471-2407-9-210

Clarke, Raymond A., Zhao, Zhongming, Guo, An-Yuan, Roper, Kathrein, Teng, Linda, Fang Zhi-Ming, Samaratunga, Hema, Lavin, Martin F. and Gardiner, Robert A. (2009). New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression.. PLoS One, 4 (3) e4995, e4995. doi: 10.1371/journal.pone.0004995

Gardiner, Robert A. and Hamdy, Freddie C. (2008). Management of low-risk prostate cancer. World Journal of Urology, 26 (5), 411-414. doi: 10.1007/s00345-008-0329-1

Kote-Jarai, Zsofia, Easton, Douglas F., Stanford, Janet L., Ostrander, Elaine A., Schleutker, Johanna, Ingles, Sue A., Schaid, Daniel, Thibodeau, Stephen, Dork, Thilo, Neal, David, Cox, Angela, Maier, Christiane, Vogel, Walter, Guy, Michelle, Muir, Kenneth, Lophatananon, Artitaya, Kedda, Mary-Anne, Spurdle, Amanda, Steginga, Suzanne, John, Esther M., Giles, Graham, Hopper, John, Chappuis, Pierre O., Hutter, Pierre, Foulkes, William D., Hamel, Nancy, Salinas, Claudia A., Koopmeiners, Joseph S., Karyadi, Danielle M. ... Eeles, Rosalind A. (2008). Multiple novel prostate cancer predisposition loci confirmed by an international study: The PRACTICAL consortium. Cancer Epidemiology Biomarkers and Prevention, 17 (8), 2052-2061. doi: 10.1158/1055-9965.EPI-08-0317

Steginga, Suzanne K., Ferguson, Megan, Clutton, Samantha, Gardiner, R. A. (Frank) and Nicol, David (2008). Early decision and psychosocial support intervention for men with localised prostate cancer: an integrated approach. Supportive Care in Cancer, 16 (7), 821-829. doi: 10.1007/s00520-007-0351-7

Drake, Marcus, Webber, Robyn and Gardiner, R. A. 'Frank' (2008). The BJU International website - Reply. Bju International, 101 (11), 1465-1466.

Gardiner, R. A. (Frank) and Fitzpatrick, John M. (2008). FingerTip Urology: illustrations for patient dialogue at the click of your cursor. BJU International, 101 (7), I-I. doi: 10.1111/j.1464-410X.2008.07545.x

Myers, Stephen A., Kaushal, Aneel, Dong, Ying, Lai, John, Tan, Olivia L., Bui, Loan T., Hunt, Melanie L., Digby, Matthew R., Samaratunga, Hemamali, Gardiner, Robert A., Clements, Judith A. and Hooper, John D. (2008). A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus. Prostate, 68 (4), 381-399. doi: 10.1002/pros.20685

Kelly Anne Landers, Samaratunga, Hemamali, Linda Teng, Buck, M., Burger, Michelle J., Betty Scells, Lavin, Martin F. and Gardiner, Robert A. (2008). Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. British Journal of Cancer, 99 (3), 491-501. doi: 10.1038/sj.bjc.6604486

Chambers, Suzanne K., Schover, Leslie, Halford, Kim, Clutton, Samantha, Ferguson, Megan, Gordon, Louisa, Gardiner, Robert A., Occhipinti, Stefano and Dunn, Jeff (2008). ProsCan for Couples: Randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy. BMC Cancer, 8 (1) 226, 226.1-226.8. doi: 10.1186/1471-2407-8-226

Chambers, Suzanne K., Ferguson, Megan, Gardiner, R. A., Nicol, David, Gordon, Louisa, Occhipinti, Stefano and Aitken, Joanne (2008). ProsCan for Men: Randomised controlled trial of a decision support intervention for men with localised prostate cancer. BMC Cancer, 8 (207) 207, 1-7. doi: 10.1186/1471-2407-8-207

Steginga, S.K. and Gardiner, R.A. (2007). The media and prostate cancer screening. Medical Journal of Australia, 187 (9), 501-502. doi: 10.5694/j.1326-5377.2007.tb01387.x

Veveris-Lowe, T. L., Kruger, S. J., Walsh, T., Gardiner, R. A. and Clements, J. A. (2007). Seminal fluid characterization for male fertility and prostate cancer: Kallikrein-related serine proteases and whole proteome approaches. Seminars in Thrombosis & Hemostasis, 33 (1), 87-99. doi: 10.1055/s-2006-958467

Steginga, Suzanne K., Smith, David P., Pinnock, Carole, Metcalfe, Robyn, Gardiner, Robert A. and Dunn, Jeff (2007). Clinicians' attitudes to prostate cancer peer-support groups. British Journal of Urology International, 99 (1), 68-71. doi: 10.1111/j.1464-410X.2006.06545.x

Gardiner, Robert A., Nicol, David L., Green, Heather J. and Pakenham, Ken I. (2006). Side-effects of treatments for locally advanced prostate cancer. BJU International, 98 (1), 229-231. doi: 10.1111/j.1464-410X.2006.06357_3.x

Gardiner, Frank (2006). Fingertip urology. BJU International, 97 (1), i-i. doi: 10.1111/j.1464-410X.2006.06043.x

Samaratunga, H., Gardiner, R.A., Yaxley, J. and Brown, I. (2006). Atypical prostatic glandular proliferations on needle biopsy - Diagnostic implications, use of immunohistochemistry, and clinical significance. Analytical And Quantitative Cytology And Histology, 28 (2), 104-110.

Dong, Y., Bui, L. T., Odorico, D. M., Tan, O. L., Myers, S. A., Samaratunga, H., Gardiner, R. A. and Clements, J. A. (2005). Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. Endocrine-Related Cancer, 12 (4), 875-889. doi: 10.1677/erc.1.01062

Dangerfield, D.C., McLarty, E. and Gardiner, R. A. (2005). Transurethral resection. BJU International, 96 (1), 189-189. doi: 10.1111/j.1464-410X.2005.05662_2.x

Landers, Kelly A., Burger, Michelle J., Tebay, Michelle A., Purdie, David M., Scells, Betty, Samaratunga, Hemamali, Lavin, Martin F. and Gardiner, Robert A. (2005). Use of multiple biomarkers for a molecular diagnosis of prostate cancer. International Journal of Cancer, 114 (6), 950-956. doi: 10.1002/ijc.20760

Green, Heather J., Pakenham, Kenneth I. and Gardiner, Robert A. (2005). Cognitive deficits associated with cancer: A model of subjective and objective outcomes. Psychology, Health and Medicine, 10 (2), 145-160. doi: 10.1080/13548500500093308

Pinzon-Charry, Alberto, Ho, Christopher S. K., Laherty, Richard, Maxwell, Tammy, Walker, David, Gardiner, Robert A., O'Connor, Linda E., Pyke, Christopher M., Schmidt, Christopher W., Furnival, Colin and Lopez, Jose´ Alejandro (2005). A population of HLA-DR+ immature cells accumulates in the blood dendritic cell compartment of patients with different types of cancer. Neoplasia, 7 (12), 1112-1122. doi: 10.1593/neo.05442

Steginga, S. K., Pinnock, C., Gardner, M., Gardiner, R. A. and Dunn, J. (2005). Evaluating peer support for prostate cancer: the Prostate Cancer Peer Support Inventory. British Journal of Urology (BJU) International, 95 (1), 46-50. doi: 10.1111/j.1464-410X.2005.05247.x

Green, H. J., Pakenham, K. I., Headley, B. C., Yaxley, J., Nicol, D. L., Mactaggart, P. N., Swanson, C. E., Watson, R. B. and Gardiner, R. A. (2004). Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. BJU International, 93 (7), 975-979. doi: 10.1111/j.1464-410X.2004.04763.x

Gardiner, R. A., Nicol, D. L., Green, H. J., Yaxley, J., Watson, R., Mactaggart, P., Headley, B. C., Swanson, C. and Pakenham, K. I. (2004). Re: The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer M. M. Cherrier, A. L. Rose and C. Higano - J Urol, 170 : 1808-1811, 2003. Journal of Urology, 172 (2), 774-774. doi: 10.1097/01.ju.0000132508.20023.08

Steginga, S. K., Occhipinti, S., Gardiner, R. A., Yaxley, J. and Heathcote, P. (2004). A prospective study of the use of alternative therapies by men with localized prostate cancer. Patient Education And Counseling, 55 (1), 70-77. doi: 10.1016/j.pec.2003.07.007

Steginga, S.K., Occhipinti, S., Gardiner, R.A., Yaxley, J. and Heathcote, P. (2004). Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer. Urology, 63 (4), 751-756. doi: 10.1016/j.urology.2003.11.017

Hrouda, David, Nicol, David and Gardiner, Robert (2003). The role of angiogenesis in prostate development and the pathogenesis of prostate cancer. Urological Research, 30 (6), 347-355. doi: 10.1007/s00240-002-0287-9

Dunglison, NT and Gardiner, RA (2003). Continent bladder stoma. World Journal of Urology, 21 (3), 123-127. doi: 10.1007/s00345-003-0319-2

Green, H. J., Pakenham, K. I., Headley, B. C., Yaxley, J., Nicol, D. L., Mactaggart, P. N., Swanson, C., Watson, R. B. and Gardiner, R. A. (2002). Altered Cognitive Function in Men Treated for Prostate Cancer with LHRH Analogues and Cyproterone Acetate: A Randomised Controlled Trial. British Journal of Urology BJU: International, 90 (4), 427-432. doi: 10.1046/j.1464-410X.2002.02917.x

Green, Heather J., Pakenham, Kenneth I., Headley, Betty C. and Gardiner, Robert A. (2002). Coping and Health-Related Quality of Life in Men With Prostate Cancer Randomly Assigned to Hormonal Medication or Close Monitoring. Psycho-Oncology, 11 (5), 401-414. doi: 10.1002/pon.599

Gardiner, R. A. (2002). Urology. Medical Journal of Australia, 176 (1), 42-42. doi: 10.5694/j.1326-5377.2002.tb04275.x

Burger, M. J., Tebay, M. A., Keith, P. A., Samaratunga, H. M., Clements, J. A., Lavin, M. F. and Gardiner, R. A. (2002). Expression analysis of delta-catenin and prostate-specific membrane antigen: Their potential as diagnostic markers for prostate cancer. International Journal of Cancer, 100 (2), 228-237. doi: 10.1002/ijc.10468

Steginga, S., Pinnock, C., Gardner, M., Dunn, J. and Gardiner, R. A. (2002). Peer support groups for prostate cancer: a snapshot in 2002. Cancer Forum, 26 (3), 169-172.

Steginga, S.K., Occhipinti, S., Gardiner, R. A., Yaxley, J. and Heathcote, P. (2002). Making decisions about treatment for localized prostate cancer. BJU International, 89 (3), 255-260. doi: 10.1046/j.1464-4096.2001.01741.x

Steginga, S. K., Occhipinti, S., Dunn, J., Gardiner, R. A., Heathcote, P. and Yaxley, J. (2001). The supportive care needs of men with prostate cancer (2000). Psycho-oncology, 10 (1), 66-75. doi: 10.1002/1099-1611(200101/02)10:1<66::AID-PON493>3.0.CO;2-Z

Green, H. J., Pakenham, K. I. and Gardiner, R. A. (2000). Effects of Luteinizing Hormone Releasing Hormone Analogs on Cognition in Women and Men: A Review. Psychology, Health and Medicine, 5 (4), 407-418. doi: 10.1080/713690212

Gardiner, R. A. (2000). Molecular and Reconstructive Urology: A coming together. World Journal of Surgery, 24 (10), 1163-1166. doi: 10.1007/s002680010195

Gardiner, R. A. (2000). Prostate cancer: what should be the sequel to diagnosis?. Medical Journal of Australia, 172 (6), 256-257. doi: 10.5694/j.1326-5377.2000.tb123938.x

Clements, J. A., Merritt, T., DeVoss, K., Swanson, C. E., Hamlyn, L., Scells, B., Rohde, P., Lavin, M. F., Yaxley, J. and Gardiner, R. A. (2000). Inactive free : total prostate specific antigen ratios in ejaculate from men with suspected and known prostate cancer, compared with young control men. BJU International, 86 (4), 453-458. doi: 10.1046/j.1464-410X.2000.00835.x

Wijkstrom, H, Cohen, SM, Gardiner, RA, Kakizoe, T, Schoenberg, M, Steineck, G and Tobisu, K (2000). Prevention and treatment of urothelial premalignant and malignant lesions. Scandinavian Journal of Urology and Nephrology, 34, 116-135. doi: 10.1080/00365590050509878

Clements, J. A., Rohde, P., Allen, V., Hyland, V. J., Samaratunga, M. L., Tilley, W. D., Lavin, M. F. and Gardiner, R. A. (1999). Molecular detection of prostate cells ejaculate and urethral washings in men with suspected prostate cancer. Journal of Urology, 161 (4), 1337-1343. doi: 10.1016/S0022-5347(01)61680-X

Teng, HS, Hardie, IR, Samaratunga, MLTH and Gardiner, RA (1998). Experimental pyeloureterectomy and calyceal neck transection with autotransplantation and bladder advancement. British Journal of Urology, 82 (6), 877-881. doi: 10.1046/j.1464-410X.1998.00863.x

Kotlovsky, A, Sillar, D, Samaratunga, M and Gardiner, R (1998). Evaluation of myectomized partial-thickness ileum in experimental bladder augmentation. Australian and New Zealand Journal of Surgery, 68 (8), 587-591. doi: 10.1111/j.1445-2197.1998.tb02106.x

Munns, J., Yaxley, J., Coomer, J., Lavin, M.F., Gardiner, R.A. and Watters, D. (1998). Evaluation of the potential of transferrin-adriamycin conjugates in the treatment of bladder cancer. British Journal of Urology, 82 (2), 284-289. doi: 10.1046/j.1464-410X.1998.00736.x

Gardiner, RA, Spork, R and Nicol, D (1997). Long-term experience with endoscopic transvesical ureterotomy. Minimally Invasive Therapy & Allied Technologies, 6 (5-6), 479-483. doi: 10.3109/13645709709153358

Gardiner, R. A., Spork, R. and Nicol, D. (1997). Long-term experience with endoscopic transvesical ureterotomy. Minimally Invasive Therapy and Allied Technologies, 6 (5-6), 479-483.

Gardiner R.A., Samaratunga M.L.T.H., Rohde P., Clements J.A., Hyland V. and Lavin M.F. (1997). Re: Malignant cytological washings from radical prostatectomy specimens: A possible mechanism for local recurrence of prostate cancer following surgical treatment of organ confined disease. Journal of Urology, 158 (3 SUPPL.), 889-889. doi: 10.1016/S0022-5347(01)64358-1

Sillar, DB, Samaratunga, MLTH, OBrien, MF, Kotlovsky, A, Mundy, AR and Gardiner, RA (1997). Intussuscepted partial-thickness ileal valve in continent urinary diversion. European Urology, 31 (1), 102-107. doi: 10.1159/000474427

Watters, D, Garrone, B, Gobert, G, Williams, S, Gardiner, R and Lavin, M (1996). Bistratene A causes phosphorylation of talin and redistribution of actin microfilaments in fibroblasts: Possible role for PKC-δ. Experimental Cell Research, 229 (2), 327-335. doi: 10.1006/excr.1996.0378

Gardiner, RA, Samaratunga, MLTH, Gwynne, RA, Clague, A, Seymour, GJ and Lavin, MF (1996). Abnormal prostatic cells in ejaculates from men with prostatic cancer - A preliminary report. British Journal of Urology, 78 (3), 414-418. doi: 10.1046/j.1464-410X.1996.00089.x

Gardiner R.A. (1995). Urological tumours: Recent changes. Australian and New Zealand Journal of Surgery, 65 (5), 350-358. doi: 10.1111/j.1445-2197.1995.tb00654.x

Lavin, MF, Bennett, I, Ramsay, J, Gardiner, RA, Seymour, GJ, Farrell, A and Walsh, M (1994). Identification of a potentially radiosensitive subgroup among patients with breast-cancer. Journal of the National Cancer Institute, 86 (21), 1627-1634. doi: 10.1093/jnci/86.21.1627

Gardiner, RA (1994). Prostatic-Cancer. Australian and New Zealand Journal of Surgery, 64 (6), 387-388. doi: 10.1111/j.1445-2197.1994.tb02235.x

Gardiner, RA, Walsh, MD, Allen, V, Rahman, S, Samaratunga, Mlth, Seymour, GJ and Lavin, MF (1994). Immunohistological Expression of P53 in Primary Pt1 Transitional-Cell Bladder-Cancer in Relation to Tumor Progression. British Journal of Urology, 73 (5), 526-532. doi: 10.1111/j.1464-410X.1994.tb07638.x

Walsh, MD, Hohn, BG, Thong, W, Devine, PL, Gardiner, RA, Samaratunga, Mlth and McGuckin, MA (1994). Mucin Expression by Transitional-Cell Carcinomas of the Bladder. British Journal of Urology, 73 (3), 256-262. doi: 10.1111/j.1464-410X.1994.tb07514.x

Watters, DJ, Beamish, HJ, Marshall, KA, Gardiner, RA, Seymour, GJ and Lavin, MF (1994). Accumulation of HL-60 leukemia cells in G2/M and inhibition of cytokinesis caused by two marine compounds, bistratene A and cycloxazoline. Cancer Chemotherapy and Pharmacology, 33 (5), 399-409. doi: 10.1007/BF00686269

Gardiner R.A. (1994). The invaginated sleeve technique for a continent cystostomy - Five years' clinical experience. British Journal of Urology, 74 (1), 35-39. doi: 10.1111/j.1464-410X.1994.tb16542.x

Samaratunga, H, Hohn, BG, Walsh, MD, Gardiner, RA, Devine, PL and McGuckin, MA (1993). Mucin Inclusions in Urothelial Carcinomas. Human Pathology, 24 (8), 929-930. doi: 10.1016/0046-8177(93)90147-9

Png, Kbf, Walsh, MD, Seymour, GJ, Lavin, MF and Gardiner, RA (1993). THE ADVERSE EFFECT OF FIBRIN‐CLOT INHIBITING DRUGS ON INTRAVESICAL BACILLUS CALMETTE‐GUÉRIN EFFICACY FOR SUPERFICIAL BLADDER CANCER. Australian and New Zealand Journal of Surgery, 63 (2), 127-130. doi: 10.1111/j.1445-2197.1993.tb00060.x

Gardiner, RA, Samaratunga, Mlth, Walsh, MD, Seymour, GJ and Lavin, MF (1992). An Immunohistological Demonstration of C-Erbb-2 Oncoprotein Expression in Primary Urothelial Bladder-Cancer. Urological Research, 20 (2), 117-120. doi: 10.1007/BF00296522

Gardiner, RA, Mills, GA, Rivory, LP and Samaratunga, Mlth (1990). Evaluation of a Bladder Advancement Extension Graft Technique. British Journal of Urology, 66 (6), 606-612. doi: 10.1111/j.1464-410X.1990.tb07191.x

Watters, D, Marshall, K, Hamilton, S, Michael, J, McArthur, M, Seymour, G, Hawkins, C, Gardiner, R and Lavin, M (1990). The bistratenes: new cytotoxic marine macrolides which induce some properties indicative of differentiation in HL-60 cells. Biochemical Pharmacology, 39 (10), 1609-1614. doi: 10.1016/0006-2952(90)90528-S

Gardiner, RA and Samaratunga, Mlth (1990). Application of the Invaginated Sleeve Technique to Form a Continent Ileal Urostomy. British Journal of Urology, 65 (5), 457-461. doi: 10.1111/j.1464-410X.1990.tb14786.x

Smith, NW, Strutton, GM, Walsh, MD, Wright, GR, Seymour, GJ, Lavin, MF and Gardiner, RA (1990). Transferrin Receptor Expression in Primary Superficial Human Bladder Tumours Identifies Patients who Develop Recurrences. British Journal of Urology, 65 (4), 339-344. doi: 10.1111/j.1464-410X.1990.tb14752.x

Freer E., Savage N.W., Seymour G.J., Dunn T.L., Lavin M.F. and Gardiner R.A. (1990). RAS oncogene product expression in normal and malignant oral mucosa.. Australian dental journal, 35 (2), 141-146. doi: 10.1111/j.1834-7819.1990.tb05880.x

Gardiner, RA and Samaratunga, Mlth (1989). Development of the Invaginated Sleeve Technique for Continent Cystostomies in Dogs. British Journal of Urology, 63 (3), 276-280. doi: 10.1111/j.1464-410X.1989.tb05189.x

Strutton G.M., Gemmell E., Seymour G.J., Walsh M.D., Lavin M.F. and Gardiner R.A. (1989). An immunohistological examination of inflammatory cell infiltration in primary testicular seminomas. Australian and New Zealand Journal of Surgery, 59 (2), 169-172. doi: 10.1111/j.1445-2197.1989.tb01491.x

Dunn, TL, Seymour, GJ, Gardiner, RA, Strutton, GM and Lavin, MF (1988). Immunocytochemical Demonstration of P21Ras in Normal and Transitional Cell-Carcinoma Urothelium. Journal of Pathology, 156 (1), 59-65. doi: 10.1002/path.1711560112

Hayward, NK, Keegan, R, Nancarrow, DJ, Little, MH, Smith, PJ, Gardiner, RA, Seymour, GJ, Kidson, C and Lavin, MF (1988). C-Ha-Ras-1 Alleles in Bladder-Cancer, Wilms Tumor and Malignant-Melanoma. Human Genetics, 78 (2), 115-120. doi: 10.1007/BF00278178

Gardiner R.A., McKay D.A. and Weedon D. (1988). Replacement of excised segments of proximal ureters by tubularised bladder grafts vascularised by previously established omental pedicles. Journal of Urology, 140 (4), 860-863. doi: 10.1016/S0022-5347(17)41845-3

Gemmell E., Strutton G.M., Seymour G.J., Walsh M.D., Lavin M.F. and Gardiner R.A. (1988). An immunohistopathological characterisation of mixed non-seminomatous germ cell tumors. Urological Research, 16 (1), 13-17. doi: 10.1007/BF00264622

Seymour, GJ, Walsh, MD, Lavin, MF, Strutton, G and Gardiner, RA (1987). Transferrin Receptor Expression by Human Bladder Transitional Cell Carcinomas. Urological Research, 15 (6), 341-344. doi: 10.1007/BF00265663

Dunn T.L., Gardiner R.A., Seymour G.J. and Lavin M.F. (1987). Genotoxicity of analgesic compounds assessed by an in vitro micronucleus assay.. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 189 (3), 299-306. doi: 10.1016/0165-1218(87)90061-9

Gardiner R.A., Seymour G.J., Lavin M.F., Strutton G.M., Gemmell E. and Hazan G. (1986). Immunohistochemical analysis of the human bladder. British Journal of Urology, 58 (1), 19-25. doi: 10.1111/j.1464-410X.1986.tb05420.x

Gardiner, RA (1986). Invasive Bladder-Cancer - Possible Future Treatment Considerations. Urological Research, 14 (4), 191-194. doi: 10.1007/BF00441112

Ellem, Kao and Gardiner, RA (1985). Diuretic Potentiation of Shedding of Renal Progenitor Cells. Lancet, 2 (8461), 946-947.

Gardiner, R. A. (1985). Endoscopic transvesical ureterotomy. Journal of Urology, 134 (4), 729-732. doi: 10.1016/S0022-5347(17)47411-8

Gardiner, RA, Weedon, D, Sing, J and Splatt, AJ (1984). Replacement of Ureteric Segments by Intubated Neo‐ureterotomies (Modified Davis Technique) Using Autologous Bladder and Omentum in Dogs. British Journal of Urology, 56 (4), 354-358. doi: 10.1111/j.1464-410X.1984.tb05820.x

Rolfe, BE, Morton, H, Cavanagh, AC and Gardiner, RA (1983). Detection of An Early-Pregnancy Factor-Like Substance in Sera of Patients with Testicular Germ-Cell Tumors. American Journal of Reproductive Immunology, 3 (2), 97-100. doi: 10.1111/j.1600-0897.1983.tb00223.x

Gardiner, RA, Weedon, D, Askew, AR and Splatt, AJ (1982). Replacement of Segments of Excised Ureters by Omentally Wrapped Partial Thickness Bladder Grafts in Dogs - a Preliminary-Report. British Journal of Urology, 54 (3), 216-219. doi: 10.1111/j.1464-410X.1982.tb06961.x

Gardiner, RA (1981). Radiocolloid Scintigraphic Mapping of the Lymphatic Drainage of the Prostate. Journal of Urology, 125 (2), 268-268. doi: 10.1016/S0022-5347(17)55004-1

Splatt D.A., Weedon D., Boyle P.D. and Gardiner R.A. (1981). Inflammatory ureteric polyp associated with analgesic nephropathy. Australian and New Zealand Journal of Surgery, 51 (1), 81-83. doi: 10.1111/j.1445-2197.1981.tb05914.x

Gardiner, RA, Masters, Jrw and Molland, EA (1980). Experimental Trypsin-Induced Urothelial Cell-Separation Invivo. British Journal of Urology, 52 (4), 295-300. doi: 10.1111/j.1464-410X.1980.tb08920.x

Fitzpatrick, JM, Gardiner, RA, Williams, JP, Riddle, PR and Odonoghue, Epn (1980). Pituitary Ablation in the Relief of Pain in Advanced Prostatic-Carcinoma. British Journal of Urology, 52 (4), 301-304. doi: 10.1111/j.1464-410X.1980.tb08921.x

Gardiner, RA, Nauntonmorgan, TC, Whitfield, HN, Hendry, WF and Wickham, Jea (1979). The Modified Lumbotomy Versus the Oblique Loin Incision for Renal Surgery. British Journal of Urology, 51 (4), 256-259. doi: 10.1111/j.1464-410X.1979.tb04704.x

Gardiner, RA, Fitzpatrick, JM, Constable, AR, Cranage, RW, Odonoghue, Epn and Wickham, Jea (1979). Human Prostatic Lymphoscintigraphy. A Preliminary Report. British Journal of Urology, 51 (4), 300-303. doi: 10.1111/j.1464-410X.1979.tb04713.x

Gardiner, RA, Fitzpatrick, JM, Constable, AR, Cranage, RW, Odonoghue, Epn and Wickham, Jea (1979). Improved Techniques in Radionuclide Imaging of Prostatic Lymph-Nodes. British Journal of Urology, 51 (6), 561-564. doi: 10.1111/j.1464-410X.1979.tb03602.x

Fitzpatrick, JM, Gardiner, RA and Worth, Phl (1979). Evaluation of 68 Patients with Post-Prostatectomy Incontinence. British Journal of Urology, 51 (6), 552-555. doi: 10.1111/j.1464-410X.1979.tb03600.x

Gardiner, RA, Flynn, JT, Paris, Ami and Blandy, JP (1978). One-Stage Island Patch Urethroplasty. British Journal of Urology, 50 (7), 575-577.

Conference Papers

Taaffe, Dennis R., Newton, Robert U., Chambers, Suzanne K., Spry, Nigel, Joseph, David, Gardiner, Robert A., Hayne, Dickon and Galvao, Daniel A. (2024). Immediate Versus Delayed Exercise In Patients Initiating Androgen Deprivation Therapy: Effects On Quality Of Life. American College of Sports Medicine Annual Meeting 2024, Boston, MA United States, 28 - 31 May 2024. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1249/01.mss.0001061932.99323.15

Taaffe, Dennis R., Newton, Robert Usher, Spry, Nigel, Chambers, Suzanne K., Gardiner, Robert Alexander, Lopez, Pedro, Joseph, David John and Galvao, Daniel Abido (2023). Effect of exercise mode specificity on quality of life in prostate cancer patients undergoing androgen suppression. ASCO Breakthrough 2023, Yokohama, Japan, 3-5 August 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/go.2023.9.supplement_1.72

Galvao, Daniel Abido, Chambers, Suzanne K., Taaffe, Dennis R., Cormie, Prue, Schumacher, Oliver, Gardiner, Robert Alexander, Spry, Nigel, Lopez, Pedro, Joseph, David John, Tang, Colin, Hayne, Dickon and Newton, Robert Usher (2023). Effects of supervised exercise and self-managed psychosexual therapy on sexual health in men with prostate cancer: A randomized clinical trial. ASCO Breakthrough 2023, Yokohama, Japan, 3-5 August 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/go.2023.9.supplement_1.71

Nair-Shalliker, V., Rodge, J., Woo, H., Yaxley, J., Rasiah, K., Patel, M., Gillatt, D., Frydenberg, M., Malouf, D., Ende, D., Mancuso, P., Kimlin,, Gardiner, R., Gebski, V., Fenech, M., Smith, D. and Gurney, H. (2018). A phase II randomised control trial of high dose vitamin D in localised prostate cancer patients with intermediate risk of disease progression - ProsD. ANZUP Annual Scientific Meeting: Putting People First, Sydney, Australia, 8-10 July 2018. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Hyde, Melissa, Newton, Robert, Galvao, Daniel, Gardiner, Robert, Occhipinti, Stefano, Lowe, Anthony, Wittert, Gary and Chambers, Suzanne (2016). Prostate-cancer related concerns of men in the first year after localised prostate cancer diagnosis and decisions to seek help. World Congress of Psycho-oncology, Dublin, Ireland, 17 – 21 October 2016. Oxford, United Kingdom: John Wiley & Sons.

Gardiner, Robert ('Frank'), Yaxley, John W., Coughlin, Geoffrey D., Chambers, Suzanne K., Occhipinti, Stefano, Samaratunga, Hema, Zaidlewicz, Leah, Dunglison, Nigel, Carter, Rob, Williams, Scott, Payton, Diane J., Perry-Keene, Joanna and Lavin, Martin F. (2016). A Randomized Controlled Trial of Robotic Versus Open Radical Prostatectomy: Early Outcomes. ANZUP Annual Scientific Meeting, GU Cancer: Expanding our Horizons, Brisbane, Australia, 10-12 July 2016. West Sussex, United Kingdom: Wiley. doi: 10.1111/ajco.12557

Hart, Nicolas, Newton, Robert U., Taaffe, Dennis R., Spry, Nigel, Joseph, David, Cormie, Prue, Chambers, Suzanne K., Gardiner, Robert A. and Galvao, Daniel A. (2015). Musculoskeletal comparison of patients with localised versus metastatic prostate cancer. 2nd Prostate Cancer World Congress (PCWC), Cairns, QLD, Australia, 17-21 August 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/bju.13197

Ashrafi, D., Baade, P., Yaxley, J., Roberts, M., Williams, S. and Gardiner, R. A. (Frank) (2015). Long term survival outcomes for men who provided ejaculate specimens for prostate cancer research: implications for patient management. USANZ 2015: 68th Annual Scientific Meeting including 20th Annual Meeting of the Australia and New Zealand Urological Nurses Society, Adelaide, SA Australia, 11-14 April 2015. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Galvao, Daniel Abido, Newton, Robert Usher, Gardiner, Robert Alexander, Girgis, Afaf, Lepore, Stephen, Stiller, Anna, Mihalopolous, Cathrine, Occhipinti, Stefano Stefano and Chambers, Suzanne K. (2015). Australian prostate cancer survivors compliance to contemporary aerobic and resistance exercise oncology guidelines and associations with psychological distress, unmet supportive care needs and quality of life.. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, United States, May 29-Jun 02, 2015.

Zajdlewicz, L., Chambers, S. K. and Gardiner, R. A. (2014). Psychological Distress and Advanced Prostate Cancer. ANZUP Annual Scientific Meeting, From ideas to outcomes: Patient focused research, Melbourne, VIC Australia, 13-15 July 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12223_5

Chambers, Suzanne K., Lowe, Anthony, Hyde, Melissa K., Zajdlewicz, Leah, Gardiner, Robert A., Oam, David Sandoe and Dunn, Jeff (2014). Defining Young in the Context of Prostate Cancer. 11th Annual Conference of the American Psychosocial Oncology Society, Tampa, Fl United States, 13-15 February 2014. Chichester, West Sussex, United Kingdom: John Wiley and Sons. doi: 10.1002/pon.3478

McDowall, R., Chambers, S. K., Smith, D. P., Berry, M., Lepore, S., Foley, E., Clutton, S., Occhipinti, S., Frydenberg, M. and Gardiner, R. A. (2014). Baseline Characteristics of the Participants in a Telephone-Delivered Mindfulness Intervention for Men with Advanced Prostate Cancer. ANZUP Annual Scientific Meeting, From ideas to outcomes: Patient focused research, Melbourne, VIC Australia, 13-15 July 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12223_5

Roberts, M. J., Selth, L. A., Chow, C. W. K., Doi, S. A. R., Vincent, A., Butler, L. M., Lavin, M. F., Tilley, W. D. and Gardiner, R. A. (2014). Seminal fluid microRNAs: new, non-invasive biomarkers for prostate cancer. 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Brisbane, QLD Australia, 16-19 March 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

Gardiner, R. A., Mactaggart, P., Yaxley, J., Nicol, D., McClintock, S., Ellem, K., Hart, D., Seymour, G. J., Lopez, A. and Schmidt, C. (2014). Survival outcomes for men with castrate-resistant prostate cancer (CRPC) treated with a dendritic-cell based vaccine in a randomized controlled trial. 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Brisbane, QLD Australia, 16-19 March 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

Gardiner, R. A., Mactaggart, P., Yaxley, J., Nicol, D., McClintock, S., Ellem, K. A. O., Hart, D., Seymour, G. J., Lopez, A. and Schmidt, C. (2014). Survival outcomes for men with castrate-resistant prostate cancer (CRPC) treated with a dendritic-cell based vaccine in a randomized controlled trial. ANZUP Annual Scientific Meeting, Melbourme, VIC Australia, 13-15 July 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12223_5

Roberts, M. J., Williamson, D. A., Hadway, P., Doi, S. A. R., Paterson, D. L. and Gardiner, R. A. (2014). Does baseline prevalence or targeted prophylaxis reduce infectious complications after prostate biopsy? A bias-adjusted meta-analysis. 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Brisbane Australia, 16 - 19 March 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing Ltd.. doi: 10.1111/bju.12618

Bennett, H., Roberts, M., Doi, S. A. R. and Gardiner, R. A. (2014). Major complications following prostate biopsy: a meta-analysis of the international literature. 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Brisbane, QLD Australia, 16-19 March 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

Newton, Robert U., Galvao, Daniel A., Spry, Nigel, Cormie, Prue, Chambers, Suzanne K., Gardiner, Robert A., Shum, David H., Joseph, David and Taaffe, Dennis R. (2014). Musculoskeletal Effects of Exercise in Men with Prostate Cancer Initiating Androgen Deprivation Therapy. 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, VIC Australia, 2-4 December 2014. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12305

Chambers, Suzanne K., Schover, Leslie, Nielsen, Lisa, Halford, Kim, Clutton, Samantha, Gardiner, Robert A., Dunn, Jeff and Occhipinti, Stefano (2013). Couple distress after localised prostate cancer. Prostate Cancer World Congress and 14th Australasian Prostate Cancer Conference, Melbourme, VIC Australia, 6-10 August 2013. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing Ltd.. doi: 10.1111/bju.12294

Chambers, Suzanne, Newton, Robert, Girfis, Afaf, Stiller, Anna, Lepore, Stephen, Mihalopoulos, Cathrine, Gardiner, R. A. 'Frank', Galvao, Daniel and Occhipinti, Stefano (2013). Physical activity, health & wellbeing among men with localised prostate cancer in Queensland: baseline data from the living with prostate cancer study. Prostate Cancer World Congress and 14th Australasian Prostate Cancer Conference, Melbourme, VIC Australia, 6-10 August 2013. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing Ltd. doi: 10.1111/bju.12294

Chambers, S. K., Schover, L., Halford, K., Clutton, S., Ferguson, M., Gardiner, R. A., Occhipinti, S. and Dunn, J. (2013). Sexuality support for couples following prostate cancer diagnosis: peer support as a care approach. Cancer Survivorship and Sexual Health Symposium, Washington, DC, USA, 17-19 June 2011. United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/jsm.12079

Gardiner, R. A., Coughlin, G., Yaxley, J., Dunglison, N., Occhipinti, S., Younie, S., Carter, R., Williams, S., Lavin, M. and Chambers, S. K. (2013). A Randomised Open and Robotic Prostatectomy: Trial Methodology. ANZUP Annual Scientific Meeting Advancing genitourinary cancer care through research and collaboration, Gold Coast, QLD Australia, 14 - 16 July 2013. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing Ltd.. doi: 10.1111/ajco.12098_4

Roberts, M., Teng, L., Buck, M., Schirra, H., Hancock, J., Clarke, R., Samaratunga, H., Zenzmaier, C., Lavin, M. and Gardiner, R. (2012). Molecular and metabonomic ejaculate profiling enables prostate cancer detection. 65th Annual Scientific Meeting on Urological Society of Australia and New Zealand, Darwin, NT, Australia, 21-24 April 2012. Oxford England U.K.: Wiley-Blackwell Publishing. doi: 10.1111/j.1464-410X.2012.11074.x

Baade, Peter D., Youlden, Danny R., Gardiner, Robert A., Ferguson, Megan, Aitken, Joanne F., Yaxley, John and Chambers, Suzanne K. (2012). Factors associated with diagnostic and treatment intervals and the treatment received by prostate cancer patients in Queensland. The Joint Meeting of the COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho–Oncology, Brisbane Australia, 13-15 November 2012. West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12030

Chambers, S. K., McDowall, R. J., Schover, L., Nielsen, L., Halford, K., Gardiner, R. A., Dunn, J. and Occhipinti, S. (2012). Couple distress following prostate cancer diagnosis. ANZUP Annual Scientific Meeting, State of the art Multi-Disciplinary Care in Urological Cancers, Sydney Australia, 15-17 July 2012. West Sussex , United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/j.1743-7563.2012.01575.x

Gardiner, R. A., Buck, M., Teng, L., Schirra, H. J., Roberts, M. J., Zenzmaier, C., Hancock, J., O'Rourke, P., Samaratunga, M. L. T. H., Scells, B., Payton, J. D., Perry-Keene, J., Yaxley, J., Coughlin, G. and Lavin, M. F. (2011). Multiple markers in prediction of prostate cancer from ejaculate. 20th Annual RBWH Health Care Symposium: Personalised Health Care, Brisbane, Australia, 10 -14 October 2011.

Gardiner, R. A., Teng, L., Buck, M., Hancock, J., Clarke, R., Samaratunga, H., Schirra, H. J., Zenzmaier, C., Berger, P., Catto, J., Yaxley, J., Gianduzzo, T., Coughlin, G. and Lavin, M. F. (2011). Multiple markers in prostate cancer detection from ejaculate. 64th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Christchurch, New Zealand, 21-24 February 2011. Oxford, U.K.: Wiley-Blackwell Publishing. doi: 10.1111/j.1464-410X.2011.9997.x

Roberts, M. J., Schirra, H. J., Teng, L., Lavin, M. F. and Gardiner, R. A. (2011). Prostate cancer metabolomics: An emerging method of screening and diagnosis. Australian Society for Medical Research Queensland Postgraduate Student Conference, Brisbane, Australia, 31 May 2011.

Roberts, M. J., Schirra, H. J., Teng, L., Lavin, M. F. and Gardiner, R. A. (2011). Prostate cancer metabolomics: Novel, robust, promising. 3rd UQMS Research Colloquium, Brisbane, Australia, 15th August 2011.

Roberts M. J., Schirra H. J., Lavin M. F. and Gardiner R. A. (2011). This won’t hurt a bit – NMR-based metabolomics in medical diagnosis of prostate cancer. ANZMAG-2011 – the Australian and New Zealand Society for Magnetic Resonance, Torquay, Victoria, 12th October 2011.

Schirra, H. J., Roberts, M. J., Lavin, M. F. and Gardiner, R. A. (2011). This won’t hurt a bit – NMR-based metabolomics in medical diagnosis of prostate cancer. 7th International Conference of the Metabolomics Society, Cairns, Australia, 27 - 30 June 2011.

Roberts, M. J., Schirra, H. J., Teng, L., Lavin, M. F. and Gardiner, R. A. (2011). Urine and ejaculate link local pathophysiology with systemic metabolic changes in Prostate Cancer: A metabolomic study. 12th Australasian Prostate Cancer Conference 2011, Melbourne, Australia, 3 - 5 August 2011.

Lavin, M. F., Clarke, R. A., Teng, L., Fang, Z. and Gardiner, R. A. (2011). Relationship between the TMPRSS2-ERG gene fusion and prostate cancer metastases. 64th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Christchurch, New Zealand, 21-24 February 2011. Oxford, United Kingdom: Wiley-Blackwell Publishing.

Whitbread, Astrid K., Veveris-Lowe, Tara L., Dong, Ying, Tan, Olivia L., Gardiner, Robert, Samaratunga, Hema M., Nicol, David L. and Clements, Judith A. (2010). Expression of PSA-RP2, an alternatively spliced variant from the PSA gene, is increased in prostate cancer tissues but the protein is not secreted from prostate cancer cells. IKS 2009: 3rd International Symposium on Kallikreins and Kallikrein-Related Peptidases, Munich, Germany, 30 August-2 September 2009. Berlin, Germany: Walter de Gruyter. doi: 10.1515/BC.2010.043

Teng, L., Buck, M., Hancock, J., Clarke, R., Samaratunga, H., Schirra, H., Zenzmaier, C., Berger, P., Catto, J., Yaxley, J., Gianduzzo, T., Coughlin, G., Lavin, M. and Gardiner, R. (2010). Multiple markers in prostate cancer detection in ejaculate. URS, USANZ Meeting 2010, Nelson, New Zealand, 10-12 November, 2010.

Teng, L., Buck, M., Scells, B., Clarke, R. A., Samaratunga, M. L. T. H., Yaxley, J., Gianduzzo, T., Coughlin, G., Lavin, M. F. and Gardiner, R. A. (2010). Molecular and metabonomic profiling of ejaculate fluid in prostate cancer detection. 63rd Annual Meeting of the Urological Society of Australia and New Zealand, Perth, Australia, 21-24 February 2010. Oxford, U.K.: Wiley-Blackwell Publishing. doi: 10.1111/j.1464-410X.2010.09122.x

Teng, L., Buck, M., Scells, B., Samaratunga, M. L. T. H., Yaxley, J., Lavin, M. F. and Gardiner, R. A. (2009). Molecular profiling of prostatic fluid in prostate cancer detection. 62nd Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Gold Coast Australia, Mar 08-12, 2009. MALDEN: WILEY-BLACKWELL PUBLISHING, INC.

Chambers (Steginga), S. K., Ferguson, M., Nicol, D., Gardiner, R. A. and Aitken, J. (2009). Clinical care pathways for the treatment of prostate cancer in Queensland, Australia: the ProsCan Study. 62nd Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Gold Coast Australia, Mar 08-12, 2009. MALDEN: WILEY-BLACKWELL PUBLISHING, INC.

Gardiner, R. A., Schmidt, C., Ellem, K. A. O., Lopez, A., Scells, B., O'Connor, L., Nicol, D. L., McClintock, P. and Yaxley, J. (2009). A Phase I vaccine study with metastatic tumour as the antigen source in patients with advanced castrate-resistant prostate cancer. 62nd Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Gold Coast Australia, Mar 08-12, 2009. MALDEN: WILEY-BLACKWELL PUBLISHING, INC.

Teng, L., Buck, M., Yameen, Z., Scells, B., Samaratungas, M. L. Th., Yaxle, J., Stening, S., Lavin, M. F. and Gardiner, R. A. (2008). PCA3 and Claudin 4 in prostate tissue and prostatic fluid. 61st Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Hong Kong Peoples R China, Feb 24-28, 2008. OXFORD: BLACKWELL PUBLISHING.

Gardiner, R. A., Schmidtt, C., Ellem, K. A. O., Hart, D., Seymour, G. J., Lopez, A., Scells, B., O'Connor, L., Nicol, D. L., Mactaggart, P., Mcclintock, P. and Yaxley, J. (2008). A randomised controlled study of a DC-based vaccine study in patients with hormone escaping prostate cancer. 61st Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Hong Kong Peoples R China, Feb 24-28, 2008. OXFORD: BLACKWELL PUBLISHING.

Gardiner, R. A., Burger, M. J., Landers, K. A., Roper, K., Scells, B., Samaratunga, M. L. T. H., Yaxley, J., Stening, S. and Lavin, M. F. (2007). Multiple molecular markers in the diagnosis of prostate cancer from prostatic fluid. Urological Society of Australia and New Zealand 60th Annual Scientific Meeting, Adelaide, Australia, 18-22 February 2007. London, UK: Blackwell Science. doi: 10.1111/j.1464-410X.2007.06719.x

Green, H. J., Pakenham, K., I and Gardiner, R. A. (2006). Adjustment and quality of life of men and their partners during treatment for non-localised prostate cancer. MALDEN: WILEY-BLACKWELL.

Ngo, T., Burger, M., Landers, K., Scells, B., Samaratunga, H., Lavin, M. and Gardiner, R. A. (2006). DD3 expression in metastatic prostate cancer. The Urological Society of Australasia Annual Scientific Meeting 2006, Brisbane, Qld., Australia, 26-30 March 2006. Oxford, U.K.: Wiley-Blackwell Publishing. doi: 10.1111/j.1464-410X.2006.06085_17.x

Burger, M. J., Landers, K. A., Roper, K., Samaratunga, M. L. T. H., Yaxley, J., Stening, S., Lavin, M. F. and Gardiner, R. A. (2006). Prostrate cancer: molecular diagnosis from prostatic fluid. Urological Society of Australasia Annual Scientific Meeting, Brisbane, Australia, 26‐30 March 2006. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/j.1464-410X.2006.06085_18.x

Rao, R., Thomas, B., Dunglison, N., Gardiner, R. A., Yaxley, J., Peters, J. and Costello, A. (2006). Prostate biopsy: Common practices and differences amongst Australian and New Zealand urologists. The Urological Society of Australasia Annual Scientific Meeting 2006, Brisbane, QLD Australia, 26-30 March 2006. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/j.1464-410X.2006.06085_5.x

Burger, M. J., Landers, K. A., Roper, K., Samaratunga, M. L. T. H., Yaxley, J., Stening, S., Lavin, M. F. and Gardiner, R. A. (2006). Prostate cancer : Molecular diagnosis from prostatic fluid. The Urological Society of Australasia Annual Scientific Meeting 2006, Brisbane, QLD Australia, 26-30 March 2006. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/j.1464-410X.2006.06085_17.x

Steginga, S. K., Clutton, S., Gardiner, R. A., Nicol, D. L., Heathcote, P., James, T., Wood, G. and Yaxley, J. (2006). A novel approach to decision support for men diagnosed with prostate cancer: The proscan study. The Urological Society of Australasia Annual Scientific Meeting 2006, Brisbane, QLD Australia, 26-30 March 2006. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/j.1464-410X.2006.06085_1.x

Gardiner, RA, Landers, KA, Burger, MJ, Scells, B, Samaratunga, MLTH and Lavin, MF (2005). Claudin 4: a new therapeutic target for prostate cancer?. Annual Scientific Meeting of the Urological- Society-of-Australasia, Melbourne Australia, Feb 13-17, 2005. OXFORD: BLACKWELL PUBLISHING.

Pinzon-Charry, A., Ho, C. S . K., Laherty, R., Maxwell, T., Walker, D., Gardiner, R. A., O'Connor, L., Pyke, C., Schmidt, C. W., Furnival, C. and Lopez, J. A. (2005). Population of HLA-DR+ Immature Cells Accumulate in the Blood Dendritic Cell Compartment of Patients with Different Types of Cancer. The 35th Annual Scientific Meeting of the Australasian Society for Immunology and 14th International HLA & Immunogenetics Workshop: 'Genetics and The Immune Response', Melbourne, Australia, 29 November - 2 December 2005. Copenhagen: BLACKWELL PUBLISHING INC. doi: 10.1111/j.1399-0039.2005.00523.x

Gardiner, R. A., Walsh, T., Clements, J. A., Krugher, S., McVinish, R. and Pettitt, A. (2005). Molecular mass analyses: limitations in discriminating healthy from diseased samples in prostate cancer. Annual Scientific Meeting of the Urological Society of Australasia, Melbourne, Australia, 13-17 February 2005. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

Steginga, S., Pinnock, C., Gardner, M., Dunn, J. and Gardiner, R. A. (2004). Sociodemographic and quality of life characteristics of prostate cancer support group participants in Australia and predictors of perceived support. 4th National Prostate Cancer Symposium, Melbourne, Australia, Aug, 2003. Wiley - Blackwell Publishing Ltd. doi: 10.1111/j.1445-2197.2004.03013.x

Veveris-Lowe, T., Nicol, D. L., Gardiner, R. A. and Clements, J. A. (2001). Expression of prostate-specific antigen variant MRNA transcripts in prostate cancer and benign prostatic hyperplasia. 2001 Annual Scientific Meeting of the Urological Soc. of Australasia, Coolum, Australia, March 2001. Australia: Blackwell Publishing. doi: 10.1046/j.1445-2197.2002.t01-1-00072.x

Green, H., Yaxley, J., Nicol, D. L., Headley, B. C., Pagenham, K., Mactaggart, P. N., Watson, R. B., Swanson, C. and Gardiner, R. A. (2001). Cognition and hormonal manipulation in prostate cancer. 2001 Annual Scientific Meeting of the Urological Society of Australasia, Coolum, QLD Australia, March 2001. Richmond, VIC Australia: Wiley-Blackwell.

Green, H., Pakenham, K. I. and Gardiner, R. A. (2000). Use of hormonal medication by men with metastatic prostate cancer is associated with cognitive impairment. 6th International Congress of Behavioral Medicine, Brisbane, 15 - 18 November 2000. Mahwah NJ: Lawrence Erlbaum.

Gardiner, R. A., Clements, J. A., Merritt, J., Swanson, C., De Voss, K., Hyland, V., Rohde, P., Samaratunga, M. L. and Lavin, M. F. (1999). Free/total PSA ratios in ejaculate from trusbiopsy patients. BAUS Annual Meeting, Glasgow, 21-25 June 1999. Sydney: Blackwell Science.

Gardiner, R. A., Teng, H., Hardie, I. R. and Samaratunga, M.L. (1999). Upper Tract Replacement by Bladder with renal Autotransplantation and Dexon. 51st Annual Scientific meeting of the Urological Society of a, Adelaide, March 1998. Asia: Blackwell Science.

Gardiner, R. A., Clements, J. A., Rohde, P., Hyland, V., Samaratunga, M. L., Tilley, W. D. and Lavin, M. F. (1999). Molecular detection of PSA, PSMA and apolipoprotein D in ejaculate and urethral washings. 1999 Annual Scientific meeting of Urological Society of Austa, Adelaide, Australia, 10 March 1999. Adelaide, Australia: Urological Society of Australasia.

Clements, J. A., Flanagan, J., Samaratunga, M. and Gardiner, R. A. (1999). Putative cancer specific variants of PSA and the related kallikreins, K1, K2 are also expressed in Benign prostatic hyperplasia. 51st Annual Scientific meeting of the Urological Societyof Aa, Adelaide, March 1998. Asia: Blackwell Science.

Hii, W., Gardiner, R. A., Frydenberg, F., Byron, K., Clements, J. A. and Nicol, D. L. (1999). VEGF expression in prostatic tissue. Annual Scientific meeting of the Urological Society of Australasia, Adelaide, March 1998. Asia: Blackwell Science.

Gardiner, RA and Samaratunga, H (1988). Flap-Valve Cystostomy Using An Invaginated Sleeve of Mucosa, Lamina Propria and Superficial Muscle. OXFORD: BLACKWELL SCIENCE LTD.

Gardiner, RA, Morton, H, Cavanagh, AC and Rolfe, BE (1984). Detection of An Epf-Like Substance in Sera of Patients with Testicular Germ-Cell Tumors. OXFORD: BLACKWELL SCIENCE LTD.

Rolfe, BE, Morton, H, Cavanagh, AC and Gardiner, R (1982). Production of An Epf-Like Substance by Male Germ-Cell Tumors. COPENHAGEN: MUNKSGAARD INT PUBL LTD.

Preprints

Green, H. J., Pakenham, K. I., Headley, B. C., Yaxley, J., Nicol, D. L., Mactaggart, P. N., Swanson, C., Watson, R. B. and Gardiner, R. A. (2003). Quality of Life Compared During Pharmacological Treatments and Clinical Monitoring for Non-Localised Prostate Cancer: A Randomised Controlled Trial.

Green, H. J., Pakenham, K. I. and Gardiner, R. A. (2003). Objective and Subjective Cognitive Deficits Associated with Cancer: Implications For Health Professionals.